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2 Abstract 
Being born too early or being born too small is the largest cause of neonatal 
mortality in the world. Compared to the rest of the world, Malawi has one of 
the largest burdens of preterm birth and neonatal stunting, with infection 
recognised as an important risk factor. Previous studies have used culture 
and molecular methods to identify bacteria that could be responsible for 
triggering labour and foetal growth restriction. The composition of the oral 
and vaginal microbiome has also been linked as the possible source of these 
bacteria. However, studies up to this point have been small and have not 
utilised the full potential of current sequencing technologies. In this thesis, I 
demonstrated using high-throughput sequencing of the 16S rRNA gene that 
certain organisms are associated with adverse birth outcomes. 
Contaminating bacterial taxa, PCR and sequencing error can be filtered post-
sequencing to allow reliable reconstruction of microbial communities from low 
biomass samples such as the placenta. This revealed a specific community 
structure in the placenta and foetal membranes associated with severe 
chorioamnionitis. Analysis of communities in both matched vaginal and 
placental samples increased prevalence of Peptostreptococcus anaerobius, 
Sneathia sanguinegens and Prevotella amnii were associated with a smaller 
newborn size. These results provide further evidence of the important role 
the vaginal microbiome may play in seeding organisms found on placental 
tissues and therapeutic interventions could be designed to impact these 
communities with the goal of reducing the risk of preterm birth or intrauterine 
growth restriction.  
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8 Chapter 1: Introduction 
 
8.1 Adverse birth outcomes 
The definition of preterm birth is not fixed and can vary country-to-country. In 
the UK it is defined as a delivery that occurs before 37 gestational weeks, 
and being born within this time frame leads to an increased chance of 
mortality and morbidity. These problems are exacerbated when born before 
32 weeks (1); this sub-category of preterm deliveries can be subdivided into 
very preterm births (32-28 weeks) and extremely preterm births (before 28 
weeks).  
At the turn of the millennium it was estimated that premature birth was the 
direct cause 1,080,000 neonatal deaths, world-wide, every year (2). It is 
considered the largest cause of neonatal mortality in the world (3). 
Approximately 75% of neonatal deaths occur in premature infants. In 
developed countries improved standard of care has led to a drop in mortality 
for neonates born preterm but consequently has led to an increase in 
morbidity for those extremely preterm neonates who survive. The burden of 
mortality and morbidity increases again for twin births over singletons with 
twins more likely to be delivered preterm. In the long term premature infants 
are more likely to be effected by blindness, deafness, cerebral palsy, 
stunting, learning disabilities, as well as respiratory and gastrointestinal 
problems (1,4). A lower gestational age is proportional to the increase in 
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morbidity with a UK-based study reporting 50% of neonates delivered 
between 24 and 25 weeks classified as impaired and 25% considered 
severely disabled (5). 
Intrauterine growth restriction (IUGR) resulting in low birth weight and other 
measures of neonatal size such as neonatal length and head circumference 
are also associated with both mortality and morbidity (6). Low birth weight 
itself is defined by any live birth where the infant weighs 2500 grams or less. 
Although low birth weight is strongly associated to preterm birth, it can also 
occur in babies born at term due to a number of factors that limit foetal 
growth in utero. Excluding those born preterm, infants born with low birth 
weight have a 5-30 greater risk of mortality than those born greater than 
2500g (7). In the United States it is estimated that 40% of cases of cerebral 
palsy are diagnosed in children with a very low birth weight (8). Stunting and 
small head circumference at birth is also an indicator of IUGR. Stunting is 
defined by the World Health Organisation (WHO) as being -2 standard 
deviations lower than the median Z-score for length-for-age and small head 
circumference is defined as -2 standard deviations lower than the median 
head circumference-for-age Z-score. In 2011, 165 million children worldwide 
were stunted (9).  Stunting, along with other measures of undernutrition are 
estimated to cause 3.1 million child deaths annually (9) and neonates with a 
small head circumference are at a greater risk of impairment of neurological 
function (10). The knock on effect of this mortality and morbidity can also be 
measured in state expenditure, with the USA estimated to have spent $26.2 
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billion in 2005 dealing with the medical and educational costs of these 
complications (11). 
The worldwide preterm birth rate is estimated at 9.6% (11), with the figure 
particularly low in most developed countries (12). In the UK, infant mortality 
occurred in 24.3 per 1000 preterm births compared to 1.6 per 1000 term 
births (13). Where accurate reporting has been available, preterm birth rates 
have been rising in the developed world (14), however the effect is mitigated 
by the fact that there is now a near 100% survival rate for neonates born after 
32 weeks, dropping only marginally with earlier gestational ages (13). 
Although preterm birth and IUGR are still a recognised, serious problem in 
the developed countries, relatively it is a greater risk and burden in 
developing countries. Sub-Saharan Africa is known to have the current 
largest incidence of preterm birth in the world, with preterm birth in Southern 
Africa approximated at 17.5% (95%CI, 14.6-20.3) of all births (Figure 8-1).  
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Figure 8-1: Preterm birth rate in Southern Africa in 2005 compared to 
other geographical regions. 
Data used in plot published by Beck et al (11). 
 
In Malawi, although figures vary, a recent study placed the incidence of 
preterm birth (<37 weeks gestation) at 15.1% by ultrasound assessment (15). 
This is a serious problem for such a resource poor country with current 
estimates of overall neonatal mortality (including both term and preterm 
births) ranging between 96.8 (95%CI, 84.3–111.6) per 1000 births (16) and 
33 per 1000 births (17) in 2010. This figure rises even further to 132 per 1000 
births in children born preterm (18). Complications due to the preterm birth 
were the largest cause of mortality for babies aged between 0-27 days in 
Malawi in 2010 (Figure 8-2). 
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Figure 8-2: Causes of mortality in Malawi in 2010 for infants aged 
between 0-27 days. 
Data used to in plot published by Liu et al (19). 
 
Malawi’s health infrastructure, especially in rural areas, means that newborns 
are at a severe risk of mortality even when born after 32 weeks, whereas 
studies in the UK have just focused on those born very preterm. In Malawi, 
there is very little data on long-term morbidity of the children who survive 
being born at 32-37 weeks gestation and so the scale of the problem remains 
largely unknown. By any measure, it is more dangerous to be born at term in 
Malawi than preterm in the UK. For a child born very preterm in Malawi the 
risks are even greater, and strategies are urgently needed to bring down both 
mortality and morbidity. 
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8.2 Causes of adverse birth outcomes 
Before a clear intervention can be formulated, a better understanding of the 
pathology is needed. A number of different causes have been associated 
with preterm birth and intrauterine growth restriction, with many being inter-
connected. The mechanisms behind pregnancy and labour are complex and 
not fully understood, so it is unlikely that preterm birth itself will be a single 
aetiology but rather a culmination of multiple factors (Figure 8-3). 
 
Figure 8-3: Factors linked to an increased risk of preterm birth. 
Edited from Romero et al (20). 
 
 
Current knowledge suggests that term and preterm parturition use the same 
pathways, and so the instigator of labour must differ between the two (21). As 
well as by gestational age, preterm birth can also be split into 3 distinct types. 
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Indicated preterm birth is generally due to a maternal or foetal disorder such 
as pre-eclampsia and can be caused by smoking or obesity and, in countries 
with good healthcare coverage, can be diagnosed early culminating in an 
elective caesarean section (4,14). The other types of preterm labour are 
spontaneous and are distinguishable by delivery with intact membranes with 
regular contractions or preterm premature rupture of membranes (PPROM) 
before contractions begin. There are multiple risk factors that have been 
linked including cervical length, previous history of preterm birth, multiple 
pregnancy, stress, uteroplacental ischemia, placental abruption, intrauterine 
infection and up to 30 different SNPs have been identified as potential 
genetic markers (14,22). These include a mutation in the promotor region of 
tumor necrosis factor α that leads to oversecretion of the cytokine and 
increase in risk of preterm birth. Polymorphisms in the genes for other pro-
inflammatory cytokines such as interleukin 4, 6 and 10 have also been linked 
to a higher risk of preterm birth or premature rupture of membranes. Malawi 
also has serious region specific causes that are relatively uncommon in the 
developed countries including malnutrition, maternal malaria parasitaemia 
and HIV infection which have been shown as having a key influence on 
preterm birth (23–25).  
Microbiological studies have indicated infection as a key causative factor in 
around ~25% of preterm births, with the presence of bacteria involved in 
~80% of preterm deliveries depending on the gestational age. Exact 
mechanisms for triggering labour before 37 weeks are still unknown but they 
involve many potential risk factors that stimulate inflammatory pathways or 
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allow the spread of infection. Knowledge of a link between infection and 
preterm birth has existed since the 1970s (26) and is generally associated 
with those delivering spontaneously rather than indicated preterm births (27). 
The presence of intrauterine infection is inversely correlated with gestational 
age. Depending on the method used it identify microorganisms, amniotic fluid 
was more likely to be positive for bacteria the early the gestational age at 
delivery (28,29). This was true even in pregnancies with intact membranes. 
Viral infections as a cause of IUGR have been well studied. Human 
cytomegalovirus in particular has been shown to be able to translocate to the 
placenta and infect fetal tissue (30). Depending on the timing of these 
infections, this can impair placental development and could be an underlying 
cause of IUGR. Although work with viruses in terms of fetal growth restriction 
has been forthcoming, the same associations have not been commonly 
studied in bacteria.  
 
8.3 Chorioamnionitis 
Preterm birth or IUGR caused by infection is mediated by the recognition of 
microorganisms by the immune system (31).  Diagnosis of chorioamnionitis 
has been extensively used as evidence of intrauterine infection and is 
defined by inflammation of the chorioamnion tissues. Clinical diagnosis of 
chorioamnionitis is generally thought to be caused by hyper virulent strains of 
known human pathogens and diagnosed with the preterm rupture of 
membranes (32,33). More commonly chorioamnionitis is diagnosed 
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histologically; this is able to detect less severe but clinically relevant cases of 
inflammation. Histological chorioamnionitis (HCA) is defined by inflammatory 
cell infiltration into the placenta and membranes, however multiple semi-
quantitative definitions exist leading to discrepancy in interpretation of results 
(34). Funisitis occurs when this inflammatory process reaches the umbilical 
cord and foetuses that are exposed to severe chorioamnionitis can develop 
fetal inflammatory response syndrome (FIRS). This syndrome is defined sub-
clinically by funisitis and is a significant risk factor for perinatal mortality (35), 
fetal cardiac dysfunction (36), lung damage (37) and neurological impairment 
(38). Chorioamnionitis can put the foetus in direct risk due to migration of pro-
inflammatory cells from the site of infection or contact with potentially infected 
amniotic fluid (39). In vitro modelling of the most severe manifestations of 
chorioamnionitis show an increased incidence of systemic inflammation, 
preterm birth and foetal loss (40–42). A retrospective histopathological study 
showed that histological chorioamnionitis and funisitis were more commonly 
seen in deliveries that had neonatal sepsis, perinatal mortality or low birth 
weight (43). Chorioamnionitis is significantly more prevalent in preterm births 
than term births, and this relationship is more pronounced the earlier the 
delivery. Interestingly, chorioamnionitis is more prevalent amongst term 
deliveries in black populations (44).  
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Figure 8-4: Histologic section of chorioamnion (fetal membranes) from 
a participant showing infiltration of neutrophils (chorioamnionitis) 
between the membranes and the decidua denoted by the black arrows. 
 
 
8.4 16S rRNA gene 
Early studies used microbial culture techniques to sample and diagnose the 
presence of bacteria in the amniotic fluid and chorio-decidual space. Many 
preterm deliveries showed signs of inflammation in a number of the maternal 
and fetal tissues but there was no evidence of infection by culture. This made 
diagnosing intrauterine infection as a potential cause of preterm increasingly 
difficult (45). During this period, researchers found that measuring cytokine 
levels such as interleukin-6 was a better predictor of preterm birth than the 
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presence or absence of an infectious agent (46). Either culture techniques 
were not sensitive enough to elucidate possible infection or microbial 
invasion of the amniotic cavity is not the only infection site that triggers 
preterm birth. The limitations of classic bacteriology are well documented and 
many microbial species are uncultivable or difficult to culture at this time. 
Analysis of intrauterine infection by this technique is thought to be 
underestimating the problem. However, when bacteria have been cultured it 
was found that intra-amniotic infection was often poly microbial with multiple 
genera recovered including Ureaplasma, Mycoplasma, Fusobacterium, 
Bacteroides, Streptococcus and Gardnerella (47–50). 
The 16S ribosomal RNA gene (16S rRNA gene) has been adopted as the 
candidate gene for detecting and differentiating bacteria. It has allowed the 
application of new molecular techniques in linking infection and adverse birth 
outcomes. The gene has an important structural role in prokaryotic ribosomal 
proteins and so it is both ubiquitous and contains highly conserved regions 
across all bacteria. The primary structure of the 16S rRNA gene subunit also 
contains variable and hypervariable regions which have allowed researchers, 
beginning with Fox et al (51), to differentiate bacteria at various taxonomic 
ranks based purely on a relatively small section of their genomes. Also, the 
highly conserved secondary structure allows multiple pairwise alignments 
between these sequences enabling phylogenetic analyses. 16S rRNA 
sequencing has turned out to be a powerful method of discerning taxa 
(52,53), as well as being accurate enough to use in a clinical setting (54). 
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Figure 8-5: Distribution of variable and conserved regions in the 16S 
rRNA gene. 
Variable regions are in black and numbered. Conserved regions are in white. 
 
Studies that compared culture techniques with broad-range primers 
amplifying the 16S rRNA universally showed an increase in prevalence of 
bacteria using molecular techniques (55–60). In the context of adverse birth 
outcomes, the spectrum of genera associated with preterm delivery and the 
amniotic cavity also increased with these molecular techniques. Sanger 
sequencing of recovered 16S rDNA amplicon uncovered an increased 
number of genera recovered from the amniotic fluid of women who delivered 
preterm, including Sneathia spp., Staphylococcus spp., Prevotella spp., 
Peptostreptococcus spp., Haemophilus spp. and Leptotricihia spp. (61). 
 
8.5 Identification of bacteria in the placenta 
Much of the focus for intrauterine infection has been on bacteria recovered 
from amniotic fluid of women who deliver preterm, however it is known that 
prevalence of bacteria and even the subsequent inflammatory response can 
be common in term deliveries (62). One study in 2009 by Jones et al 
sequenced the 16S rDNA of bacteria found in the placenta and fetal 
membranes comparing neonates delivered both term and preterm. It showed 
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a greater diversity of bacteria in tissues from women who had delivered 
preterm and increased prevalence of bacteria in those born preterm 
compared to term. There were also species recovered in the preterm 
placenta and membranes not found at term such as Veillonella parvula, 
Haemophilus influenza, Peptoniphilus lacrimali, Finegoldia magna and 
Enterobacter aerogenes (63). A later study I carried out using high-
throughput sequencing found term deliveries shared many of the same 
genera, such as Streptococcus, Microbacterium, Rhodococcus and 
Corynebacterium, confirmed by two separate primer sets targeting different 
variable regions of the 16S rRNA gene (64). Six genera (Fusobacterium, 
Streptococcus, Mycoplasma, Aerococcus, Gardnerella and Ureaplasma) and 
one family (Enterobacteriaceae) which were either present in greater relative 
abundances in preterm samples or absent in term deliveries (Figure 8-6). 
There was a marked difference between the relative levels of Lactobacillus in 
the vaginal deliveries compared to caesarean sections; however this was 
expected and is easily identifiable. At the species level, Fusobacterium 
nucleatum, Mycoplasma hominis, Aerococcus christensenii, Streptococcus 
anginosus, Streptococcus agalactiae, Streptococcus spp. (mitis group) and 
Gardnerella vaginalis were all identified in the placental tissue of women who 
delivered preterm.  
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Figure 8-6: Bacteria present in placental membranes from term elective 
caesarean sections, term vaginal deliveries and preterm caesarean 
sections. 
Relative abundance of each genera are coloured by what 16S rRNA variable regions were 
used to amplify the sequencing library. The right hand heat map was sorted in descending 
order by the highest relative abundance genera identified using primers targeting V5-7. T 
CS: Term delivery by caesarean section. TL V: Term vaginal delivery. PTL V: Preterm 
vaginal delivery. This figure is the same used by the author in Placenta. 2014 Dec; 35 
(12):1099–101. 
 
 
The study provided further evidence for the role of bacteria in preterm birth. 
Bacterial DNA is present in the majority of placental membranes whether 
they are from term or preterm deliveries and irrespective of mode of delivery. 
However, the relative roles of bacterial diversity, bacterial load and host in 
the induction of preterm birth still remain to be clarified. 
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8.6 The source of placental bacteria 
Bacteria can colonise the placenta through a number of different routes, 
including ascending through the cervix from the vagina and haematogenous 
spread across the placenta. Ascending infection is characterised by a 
number of distinct stages. Firstly there is a change in the vaginal flora to 
include microbiota associated with invasion of the intrauterine cavity. This is 
usually associated with the development of bacterial vaginosis (65,66). There 
is a link between bacteria commonly found in the vagina and preterm birth 
(55,66,67). The second stage is the ascension through the cervix and 
colonisation of the decidua and chorionic membranes. Presence of bacteria 
on the fetal chorion is associated with thinning and membrane rupture which 
could lead to foetal infection (68). However, it has also known that bacteria 
can cross intact fetal membranes as well (69). Bacteria, once inside the 
amniotic cavity, can be ingested by the foetus through infected amniotic fluid 
leading to foetal bacteraemia and sepsis. 
28 
 
 
Figure 8-7: Ascending intrauterine infection. 
Adapted from Goldenberg et al (70).  
 
 
The classic view that these infectious agents invade and colonise maternal 
and fetal tissues through an ascending infection from the vagina does not 
explain the full spectrum of taxonomy recovered. There is increasing 
evidence for a haematogenous model of transmission to the placenta, 
notably from the oral cavity (71) and those bacteria can still be recovered 
from the neonate after delivery (72). A number of mouse model experiments 
have shown that infections from two organisms associated with periodontal 
disease, Porphyromonas gingivalis and Campylobacter rectus, are capable 
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of causing a number of adverse birth outcomes including low birth weight. If 
the bacteria reached the murine placenta they could inhibit a number of 
placental growth factors leading to IUGR (73–76). Using a nested PCR 
approach one recent study has shown a higher prevalence of Eikenella 
corrodens in placentas of women who had periodontitis and a higher 
prevalence of Fusobacterium nucleatum in women with periodontitis and 
preterm birth or low birth weight (77). Another study has used primers aimed 
at the 16S-23S rRNA intergenic transcribed spacer to track a a specific 
Fusobacterium nucleatum strain from a maternal origin to the gastric aspirate 
of the newborn, providing further evidence for the haematogenous spread of 
oral bacteria to the newborn (78). A systematic review looking for an 
association between periodontitis and preterm birth and low-birth weight 
found a positive correlation in nine out of ten studies (79). A recent study 
trying to define a common placental microbiome found it resembled the oral 
microbiome more than any other body site when compared against a large 
mixed population (80). This included some differences between those 
placentas recovered from term and preterm deliveries. 
The placenta and fetal membranes have been shown not to be sterile sites 
(62,80) and as techniques have become more sensitive, studies have moved 
beyond the mere detection of bacteria. Numerous microbial communities 
exist that have a commensal relationship with the host immune system, as 
well as others that are pathogenic. Advancements in current technologies for 
large-scale sequencing platforms allow greater insight and depth into distinct 
differences between these microbiomes and therefore could provide greater 
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evidence for bacteria that could be triggering adverse birth outcomes. High-
throughput sequencing has many advantages over the conventional Sanger 
sequencing including a decrease in the cost per sequence, the potential to 
uncover unlikely pathogens and the depth of coverage to provide a relatively 
unbiased profile of commensal and pathogenic bacteria (81). Although run 
time has increased compared to Sanger capillary sequencing, a single 
Illumina MiSeq run produces ~18 million paired-end reads compared to 
0.000096 million reads in a capillary sequencing run. In real terms, this 
reduces the cost per Megabase from ~£1000/Mb for Sanger sequencing to 
~£0.25/Mb for the Illumina MiSeq (82). The umbrella term high-throughput 
sequencing incorporates a number of different platforms utilising separate 
methods, however most require short template DNA (200-1000bp) and 
binding sites for forward and reverse sequencing primers. All current 
generation sequencers generate millions of sequenced reads in parallel from 
an input sample allowing the assembly of a draft genome in a single run. 
However, 16S rDNA high-throughput sequencing studies have widely 
discussed drawbacks including PCR bias (83) and reagent contamination 
(84). The lack of standardisation amongst the field also means that even 
once the data is generated, a variety of the different results can be obtained 
dependent on what downstream analysis is chosen (85). Still, the use of 
high-throughput sequencers have already been used successfully in other 
16S microbiome studies including antibiotic-associated diarrhoea (86) and 
bacterial vaginosis (87). It could be that intrauterine infection is also 
associated with a fluctuating community of bacteria, otherwise termed a 
dysbioses, rather than the isolation of a single pathogen. 
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8.7 Aims 
The main aim of this project was the characterisation of the range of 
placental microbiota found in a large cohort of women in rural Malawi and 
how community composition might associate with birth outcome. To do this I 
needed to develop and refine a protocol capable of collecting, processing 
and analysing samples in a low-income environment with greater risk of 
contamination. A secondary aim of the project was to quantify if the 
nutritional intervention that the cohort received as part of the clinical trial had 
an influence on the multiple microbiomes I measured. Additionally, I wanted 
to define both the oral and vaginal microbiomes in this group to probe 
possible sources of placental bacteria from other body sites. Lastly, due to 
the risk of ascending infection I also wanted to study the association between 
vaginal microbiota and adverse birth outcomes.  
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9 Chapter 2: General materials and methods 
 
9.1 Study design and enrolment 
All subsequent cross-sectional studies in this project were part of a larger 
clinical trial assessing whether providing Lipid-based Nutrient Supplements 
(LNS) to mothers during pregnancy and for 6 months postpartum, and to the 
infant from 6 to 18 months of age, improves child growth to a greater extent 
than prenatal iron and folic acid (IFA) or multiple micronutrient (MMN) tablets 
(88).  
Participants were enrolled prospectively into the main trial and followed 
throughout pregnancy, childbirth and beyond. Pregnant women who arrived 
for antenatal care during the enrolment period were approached for possible 
inclusion. Inclusion criteria were: ultrasound confirmed pregnancy of no more 
than 20 completed gestation weeks, residence in the defined catchment 
area, availability during the period of the study and signed or thumb-printed 
informed consent. Exclusion criteria were: age less than 15 years, need for 
frequent medical attention due to a chronic health condition, diagnosed 
asthma treated with regular medication, severe illness warranting hospital 
referral, history of allergy towards peanuts, history of anaphylaxis or serious 
allergic reaction to any substance, requiring emergency medical care, 
pregnancy complications evident at enrolment visit (moderate to severe 
oedema, blood Hb concentration < 50 g / l, systolic blood pressure (BP) > 
160 mmHg or diastolic BP > 100 mmHg), earlier participation in the iLiNS-
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DYAD-M trial (during a previous pregnancy), or concurrent participation in 
any other clinical trial. All women enrolled as part of the main trial who 
delivered were included in these analyses. 
 
9.2 Study setting 
Enrolment took place in southern Malawi in four separate study sites in the 
Mangochi district. These included one public district hospital (Mangochi), one 
semi-private hospital (Malindi) and two public health centres (Lungwena and 
Namwera). It is estimated that Magochi district hospital serves a semi-urban 
population of 100,000, while the other sites provide health care to a rural 
population of around 30,000 people each.  
 
9.3 Collection of birth outcome and baseline data 
At enrolment, participants’ weight, height and haemoglobin concentration 
were measured and obstetric history was recorded. Duration of pregnancy 
was measured using ultrasound. All participants were tested for malarial 
infection and HIV (unless they were already known to be HIV positive or 
opted out). At the first home visit to participants 1-2 weeks post-enrolment, 
information was gathered on demographic, social and economic background. 
Birth weight was measured as soon as possible after delivery while newborn 
length and newborn head circumference were measured at the infant’s first 
clinic visit at 1-2 weeks old. 
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9.4 Sample collection 
The placenta was collected after delivery and transferred to a covered sterile 
container in the hospital, health centre or home (wherever the delivery took 
place). While in the sterile container awaiting sampling temperatures ranged 
between 20°C and 40°C. Tissue sampling of the placenta occurred 
immediately after delivery, unless delivery occurred overnight (in which case 
the placenta was sampled the following morning), or at home (in which case 
the container had to be transported to the nearest study clinic first). Two 5 cm 
x 1 cm pieces of the fetal (chorionic and amniotic) membrane were taken 
from the edge of the rupture site and two 0.5 cm x 0.5 cm pieces of placental 
tissue at full thickness were taken from near the umbilical cord insertion. 
Tissue was cut using individual surgical scissors for each sample. Scissors 
were autoclaved and wiped with DNA AWAY (Thermo scientific, USA) 
between uses. One fetal membrane and one placenta sample were placed in 
separate cryovials. If the sample collection took place in Mangochi district 
hospital, the cryovials were placed at -80°C. If sample collection took place at 
an outlying health centre or Malindi hospital, the samples were stored at -
20°C for a maximum of two days before being transferred to -80°C storage at 
Mangochi district hospital. The other two placenta and fetal membrane 
samples were placed in 10% neutral buffered formalin fixative, processed 
and embedded in paraffin wax. These were sectioned at 3-5 micron thick and 
stained with haematoxylin & eosin before being read. 
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Vaginal mucus samples were taken at a postnatal visit (approx. 1 week after 
delivery), by a nurse using 4 cotton swabs. She inserted the swabs 
approximately 7 cm deep into the participant’s vagina, without a visual 
control, and rotated the swab a few times before withdrawing it. After the 
sample collection, two of these swabs were stored at -80°C for to await DNA 
extraction. 
Dental swabs were collected at Mangochi central site from all mothers who 
completed the oral health visit at one week after delivery or as soon as 
possible by specifically trained dental therapists. One sterile plastic swab 
stick with nylon fiber tip, stored in plain dry tube (microRheologics no. 552, 
Coban, Brescia, Italy) was used for the sample collection. The dental 
therapists collected the sample by rubbing the gingival margin of each tooth 
with the swab. They used dental mirror elevate the cheeks so that the teeth 
were visible and skin contact was avoided. They started the sample 
collection from the buccal side of the most posterior (farthest) tooth on the 
right upper jaw. They repeated the procedure for the palatal sites of the same 
teeth, continuing then to the lower jaw and repeating it for all lower teeth’s 
buccal and lingual side. They placed the swab immediately to a cold box with 
ice bricks. The cold box was taken to the laboratory and handed it over to a 
laboratory technician who removed the swab from the tube and cut the 
applicator stick with scissors above the fibre tip to fit the swab into cryovials 
where they were stored. Prior to cutting, they wiped the scissors with 
disinfectant to avoid contamination. They placed the cyrovial into a -
20°Cfreezer and as soon as possible, moved the swab into a -80°C freezer.  
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9.5 DNA Extraction 
DNA extraction was carried out for all sample types using the QIAmp DNA 
mini kit (Qiagen, Germany) as per the manufacturer's protocol with an 
additional cell disruption step after lysis with Proteinase K. In the additional 
step, 0.1mm glass beads (Lysing Matrix B, MP Biomedicals) were added to 
each sample and the 2ml tubes were shaken on a cell disrupter (Vortex 
Genie 2, Scientific Industries) for 10 minutes at the highest speed. For every 
10 extractions, a negative extraction control was included (200μl buffer AE). 
  
9.6 16S rDNA broad-range qPCR 
All DNA samples from placenta and fetal membranes were screened for 
bacteria using a quantitative PCR (qPCR) SYBR green fluorescent dye 
assay. The following primer pair targeted the V5-7 regions of the 16S rRNA 
gene, v785F: 5′-GGATTAGATACCCBRGTAGTC-3′, 1175R: 5′-
ACGTCRTCCCCDCCTTCCTC-3′ (64). Each PCR reaction was carried out 
with the following, 1x Power SYBR Green master mix (Life technologies), 
0.4μM of forward and reverse primers, 1µl of template DNA and molecular 
grade water (Bioline) to give a final volume of 25μl. Amplification took place 
in an ABI 7300 Real-Time system (Life) under the following conditions: 
95°C×10 min, 40 cycles of 95°C×15 sec and 60°C×1 min. Each PCR run 
included three negative PCR controls (1μl buffer AE from QIAmp DNA mini 
kit), and a serial dilution of a known amount of positive control from a pure 
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Escherichia coli culture for quantification used to calculate the bacterial load 
for each sample. 16S rRNA copy number for each E. coli dilution was 
calculated from the genome molecular weight and DNA concentration as 
measured by a Qubit 2.0 (Life technologies) and corrected for the seven 16S 
rRNA copies within the E. coli genome. Samples were defined as positive for 
bacterial DNA if their Ct value was at least 1 Ct lower than the three negative 
PCR controls (28 Ct ± 3 cycles, depending on variation between runs). 
 
9.7 16S rDNA amplicon high-throughput sequencing 
Library preparation was carried out using dual-indexed forward and reverse 
primers, with barcodes taken from a previous study (89). Both sets of primer 
sequences can be found in appendix. Each library preparation PCR was 
carried out with 1X Molzym PCR Buffer, 200 µM dNTPs (Bioline), 0.4 µM 
forward and reverse primer, 25 mM Moltaq, 5µl template DNA and molecular 
grade water (Bioline) to give a final reaction volume of 25µl. The reaction was 
amplified under the following conditions depending on the sample type. 
Placenta and fetal membrane samples were amplified under the following 
conditions: 94°C×3 min, 32 cycles of 94°C×30 sec, 60°C×40 sec and 
72°C×90 sec, with a final extension cycle of 72°C×10 min. Vaginal and oral 
swab samples were amplified under the following conditions: 94°C×3 min, 30 
cycles of 94°C×30 sec, 60°C×40 sec and 72°C×90 sec, with a final extension 
cycle of 72°C×10 min. The resulting amplicons were cleaned and pooled 
using SequalPrep normalization plate kits (Invitrogen) and AMPure XP beads 
(Beckman Coulter) both as per manufacturer’s protocol. Each plate was 
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pooled into an equimolar final library after quantification using a Qubit 2.0 
(Life technologies). Library was loaded onto a MiSeq (Illumina) as per 
manufacturer’s protocol for 500 cycle V2 kits and were multiplexed at either 
96 or 384 samples per run. Custom primers were added for read 1 
(TACCGGGACTTAGGATTAGATACCCBRGTAGTC), read 2 
(AACACGTTTTAACGTCRTCCCCDCCTTCCTC) and index 1 
(GAGGAAGGHGGGGAYGACGTTAAAACGTGTT). 
 
9.8 Bioinformatics and statistical analysis 
Paired-end 250bp sequenced reads from each MiSeq run were merged using 
FLASH with the minimum and maximum overlap changed to match the 
370bp expected amplicon (90). Merged reads were demultiplexed, pooled 
and assigned OTUs using QIIME v1.8.0 (91) at 97% similarity against a small 
custom database of full length 16S rDNA sequences and any sequences that 
failed to match at 97% were assigned against the full Greengenes database 
using UCLUST. A representative sequence was picked for each OTU cluster 
and aligned using PyNAST. Taxonomy information from Greengenes was 
added to each representative OTU using UCLUST. Parameters for all scripts 
run through QIIME can be found in the appendix. 
Mock communities were sequenced alongside samples and used to filter the 
dataset for error. Each sample was filtered based on the relative abundance 
at which the first erroneous OTU appeared in the mock community data for 
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that specific sequencing run. For most sequencing runs all OTUs occurring 
~0.8% relative abundance and below were removed.  
 
Table 9-1: Twenty member mock community control (BEI resources) 
Bacterial species  NCBI reference sequence 
Acinetobacter baumannii, strain 5377 NC_009085 
Actinomyces odontolyticus strain 1A.21 NZ_AAYI02000000 
Bacillus cereus strain NRS 248 NC_003909 
Bacteroides vulgatus strain ATCC 8482 NC_009614 
Clostridium beijerinckii strain NCIMB 8052 NC_009617 
Deinococcus radiodurans strain R1 (smooth) NC_001263, NC_001264 
Enterococcus faecalis strain OG1RF NC_17316 
Escherichia coli strain K12 substrain MG1655 NC_000913 
Helicobacter pylori strain 26695 NC_000915 
Lactobacillus gasseri strain 63 AM NC_008530 
Listeria monocytogenes strain EGDe NC_003210 
Neisseria meningitides strain MC58 NC_003112 
Propionibacterium acnes strain KPA171202 NC_006085 
Pseudomonas aeruginosa strain PAO1-LAC NC_002516 
Rhodobacter sphaeroides strain ATH 2.4.1 NC_007493, NC_007494 
Staphylococcus aureus strain TCH 1516 NC_010079 
Staphylococcus epidermidis FDA strain PCI 1200 NC_004461 
Streptococcus agalactiae strain 2603 V/R NC_004116 
Streptococcus mutans strain UA159 NC_004350 
Streptococcus pneumonia strain TIGR4 NC_003028 
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Negative controls were sequenced for screening of reagent contamination. 
SourceTracker (92) was used to predict OTUs in the placental and fetal 
membrane databases whose sources were the negative controls. These 
OTUs were removed from further analysis. After filtering, any samples with 
less than 1000 reads were also removed.  
Alpha diversity (number of unique OTUs) and beta diversity (unweighted 
UniFrac distance) were both calculated as implemented in QIIME after 
random subsampling without replacement to 1000 reads per sample. 
Diversity of microbes within an individual’s body site was summarised by 
taking the median value of their intra-individual UniFrac distances with a high 
value representing a variable community from other individuals and a lower 
value representing a stable community. The bacterial load of particular phyla, 
families or species was calculated from participant’s relative abundance and 
their overall bacteria load. Where individual bacterial loads of different 
species were calculated, 16S rRNA copy number was adjusted for those 
species accordingly. Heat map comparisons between organism relative 
abundances were produced using the R package Algorithms and framework 
for Nonnegative Matrix Factorization (NMF). 
Birth weight as measured was used if recorded within 48 h of delivery; if not, 
birth weight was back calculated from weight measured at 6 or 13 days. If the 
weight was first measured within 2 to 5 days after delivery, when infants 
usually lose weight, birth weight was estimated by applying an age-
dependent multiplicative factor to the measured weight (93). Length-for-age 
and head circumference-for-age z scores were calculated using the WHO 
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Child Growth Standards (94). Statistical analysis was carried out with Stata 
v13 and R v3.1.0. Adjusted linear regression models were used to measure 
the change in continuous outcome variables (duration of delivery, birth 
weight, LAZ and HCZ). Covariates entered into adjusted models were 
chosen based on previous literature and were entered into the model 
simultaneously in a one step, forced entry method. For comparisons between 
OTU abundances and birth outcomes, q values were calculated using the 
Benjamini-Hochberg correction to control for the false discovery rate (FDR). 
 
9.9 Ethical approval and consent 
Informed consent was granted from the mother at enrolment. Ethical 
approval was obtained from College of Medicine Research and Ethics 
Committee (COMREC), Malawi (Protocol number: P.08/10/972). The trial 
was registered at clinicaltrials.gov as NCT01239693. 
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10 Chapter 3: Development of high-throughput 16S 
rDNA amplicon sequencing method. 
 
10.1 Introduction 
An exponential rise in high-throughput sequencing microbiome studies has 
been possible because of the advances made in wet and dry laboratory 
techniques. For example, the curation of detailed 16S rDNA sequence 
databases (95) and algorithms capable of dealing with fast alignment of 
millions of sequences (96) have allowed accurate recovery of microbial 
communities from early next generation sequencers (97). Unique short DNA 
sequences that can be integrated into the 16S rDNA amplicon from specific 
samples during a PCR step allow the multiplexing of hundreds of samples in 
a single sequencing run (98). There is enough unique variety in these short 
“barcode” sequences, especially with dual indexing of the forward and 
reverse strands, to now allow multiplexing of thousands of samples (89,99). 
This technique maximises the potential read depth in the latest sequencers to 
reduce per-sample sequencing costs to their lowest point in history.  
There are many challenges facing the interpretation of 16S rRNA gene 
sequencing results. Primary extraction of genomic DNA can lead to both bias 
and contamination in later analysis (84,100). The amplicon length studied 
effects classification (101), diversity of microbes identified and their relative 
abundance, with smaller amplicons inflating the number of unique community 
members (102) and the choice of variable region studied has multiple, far-
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reaching effects on results. These include underestimation and 
overestimation of the number of OTUs in a community (103,104) and 
different taxa recovered depending on region and community analysed (105–
107). The type of full length 16S rDNA sequence database used produces 
different alignment results (85). Chimeric reads produced by PCR generation 
of the sequencing library can lead to false novel organisms being discovered 
in the community (108,109). In fact, PCR biases in general have been found 
to exhibit the greatest effect over community structure (83,110). 
Even with these drawbacks, accurate and reliable results can be generated 
with the use of the right tools and techniques (111,112). These include 
mechanical disruption of bacterial cells in the extraction and the avoidance of 
multiple freezing and thawing steps to improve recovery of all taxa (113). 
Reducing the number of PCR cycles during library preparation to prevent 
“jackpotting” and stringent quality filtering in the downstream analysis phase 
both limit the number of erroneous sequences (114,115). Larger, more 
diverse databases will allow greater breadth of taxonomic classification (116) 
whereas smaller, curated databases may be better for accurate identification 
to species level (117). There are also different advantages to using 
overlapping and non-overlapping paired-end reads (99,118) including uses a 
complete overlap to check and correct sequencing error, greatly improving 
quality (119). 
There are many bioinformatics tools now available for analysis of 16S 
amplicon data. The most popular packages combining a number of tools from 
different sources are currently Quantitative Insights Into Microbial Ecology 
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(QIIME) (91) and mothur (120). Prior to the initiation of this project there had 
not been a single study comparing microbial communities in placental tissue. 
In addition to this there was no consensus in the methods used throughout 
different microbiome projects. For these reasons I wanted to design and 
optimise a method that would be ideally suited to addressing the aims of our 
project. This included the use of a positive control material to provide quality 
control and standardisation of each method, this has been overlooked in the 
vast majority of previously  published sequencing projects (121,122).  
The aim of this chapter was to develop a high-throughput sequencing method 
for targeting the 16S rRNA gene that identified true constituents compared to 
contamination. This method would be designed to be able to process 
thousands of samples easily by a single person and would identify bacteria 
present at their greatest possible taxonomic depth in the placenta. 
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10.2 Materials and Methods 
 
10.2.1 Sample collection 
For preliminary analysis and method development, nine extra full-thickness 
placental samples were taken after delivery, in addition to the two samples 
already taken as part of the study.  These samples underwent the same 
processing and shipment as those stipulated in section 9.4. 
   
10.2.2 DNA Extraction 
The nine extra placental samples used in this preliminary work underwent the 
same extraction protocol as in section 9.5. 
 
10.2.3 16S rDNA amplicon high-throughput sequencing 
All PCR and sequencing reactions took place under the same protocols and 
conditions as stipulated in section 9.7 unless otherwise stated in the results. 
All gels were loaded with 20µl of amplified product in pre-cast 2% E-gel 
Agarose SYBR-Safe gels (Invitrogen). All bands on the gel were sized using 
either 50bp or 100bp DNA ladders (Invitrogen). For results analysing 
potential contamination of PCR reagents, a single Sanger sequencing run 
was performed on PCR amplicon using the Big-Dye 3.1 Cycle-sequencing kit 
(Thermo Fisher scientific) as per manufacturer’s instructions and was 
analysed on a 3130 Genetic Analyser (Thermo Fisher scientific). 
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10.2.4 Bioinformatics 
Primer prospector was used to perform in silico comparisons between primer 
pairs. Analyze_primers.py, get_amplicons_and_reads.py and 
taxa_assignment_report.py were used to score primers against the full 16S 
Greengenes database, generate the amplicon that would be produced and 
test the possible taxonomic depth recoverable from the amplicon using the 
RDP classifier. The script check_primer_barcode_dimers.py was used to 
check and filter possible causes of primer dimer after MiSeq compatible 
785F/1175R library preparation primers were designed. Downstream 
analysis and quality filtering of resulting FASTQ files generated from the 
MiSeq was carried out under the same protocol as stipulated in section 9.8. 
 
  
47 
 
10.3 Results 
 
10.3.1 Comparison of 16S rRNA variable region targets for optimum 
taxonomic coverage 
In order to build a representative microbiome from the placenta, fetal 
membrane, oral and vaginal samples collected in this study I compared three 
different pairs of broad-range 16S rDNA primers that targeted different 
variable regions of the 16S rRNA gene. Three potential pairs were compared 
in silico against a large database of full length 16S rDNA gene sequences 
using primer prospector (123). Two of the primer pairs chosen were 
785F/1175R and 13F/343R, both of which are used routinely by the clinical 
microbiology service at Great Ormond Street Hospital. The third primer pair, 
515F/806R, is used regularly in microbiome studies and a large number of 
individually barcoded primers have already been designed (89). Amplicons 
were built from successful hits against the entirety of the Greengenes 
database for each pair of primer sequences entered in silico. A scoring 
system based on gaps, 3’ and non-3’ mismatches was used to decide 
whether the primers would successfully generate an amplicon against a 
target 16S rDNA database sequence. It allowed for the modelling of the 
potential success or failure of using a specific primer without the costly 
process of trial and error on a high-throughput sequencer. Figure 10-1 
showed, as expected, that all primers lost coverage as they attempted to 
increase the depth of classification. Both 785F/1175R and 515F/806R 
generated a taxonomic classification for a similar number of reads in the 
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database. Primer pair 785F/1175R classified more sequences at phylum, 
class and order level compared to 515F/806R but this difference was not 
seen at the family level. 8F/3R was unable to classify a large proportion of 
taxa  within the Greengenes database and the in silico distribution of the 
length of amplicons generated was quite erratic with no clear peak as seen in 
the other primer pairs. As both 785F/1175R and 515F/806R showed similar 
high coverage they were chosen for further optimisation using placental 
samples on the MiSeq. 
 
 
Figure 10-1: In silico comparison of taxonomic coverage.  
Taxonomic coverage and classification depth predicated against the Greengenes database 
for three different potential primer pairs. Successful primer hits against the database with low 
numbers of mismatches were modelled using the Primer Prospector pipeline. Successful 
amplicons built from the entire database were then assigned taxonomy, then number of 
successfully assigned amplicons or OTUs are displayed on the y-axis. 
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Custom sequencing primers were designed with the addition of Illumina 
adapters, unique barcode sequences and an extra padding sequencing to 
lessen the likelihood of possible primer dimer. Possibility of secondary 
structure formation and primer dimer between the primers and the addition of 
the unique barcodes was checked in silico using primer prospector’s 
check_primer_barcode_dimers.py script.  
After library preparation, I compared the efficiency of the primers in 
amplifying a serial dilution of a known concentration of Escherichia coli. 
Reactions for both primer pairs were set up using the same input volume of 
template (5µl), the same number of PCR cycles (32 cycles) and the same 
unique barcode sequence (rcbc0). The annealing temperature for primers 
515F/806R (50°C) differed from 785F/1175R (60°C) as this is what was used 
previously by Caporaso et al (124). As Figure 10-2 shows, primers 
785F/1175R generated a higher concentration of amplified product when 
compared to 515F/806R.  
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Figure 10-2: Semi-quantitative comparison of product concentration 
after library preparation between 515F/806R and 785F/1175R primer 
pairs.  
Both sets of primer pairs amplified the same input concentrations of E. coli using 5µl of 
template and 32 cycles of PCR. 20µl of amplified library was visualised on 2% agarose 
SYBR Safe E-Gels (Invitrogen). 
 
 
Nine placental samples were sequenced on separate MiSeq runs using both 
the custom designed 785F/1175R primers and Caporaso et al designed 
515F/806R primers. After quality filtering and demultiplexing, the 785F/1175R 
primers generated 5,834,379 sequences with a median length of 369bp. The 
515F/806R primers generated 5,896,952 sequences with a median length of 
242bp. Analysis by the QIIME pipeline was used to see whether assembling 
longer reads allowed for greater confidence in assigning genus and species 
classifications. The reads generated by the primer pair 785F/1175R 
generated reads which both had more unique OTUs than 515F/806R and a 
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higher percentage of reads classified to both genus (77% compared to 68%) 
and species (31% compared to 23%) level (Figure 10-3) 
 
 
Figure 10-3: Comparison of OTU richness and taxonomic depth 
between two primer pairs. 
The absolute numbers of OTUs that could be confidently assigned to each classification are 
listed on the y-axis for each of the separate MiSeq runs. Each of the values at Kingdom 
classification represents 100% of the OTUs identified by that particular primer pair. 
 
 
10.3.2 Development of library preparation protocol for 
custom Illumina MiSeq runs 
To optimise library preparation for broad-range 16S rDNA specific amplicon I 
compared Taq polymerase, cycle number and reaction template volume. In 
order to try and reduce error within the PCR reaction I compared high fidelity 
polymerase (KAPA Biosystems) against an ultra-clean polymerase (Moltaq, 
Molzym). I compared both Taq polymerases using the same PCR conditions 
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for both as stipulated in section 9.5. The KAPA Taq and buffer were loaded 
as per manufacturer’s instructions. The library after PCR was visualised on a 
2% SYBR Safe agarose gel (Invitrogen). Figure 10-4 shows that negative 
controls in lanes 6 and 7 amplified using KAPA Hifi Taq, containing 5µl PCR-
grade water (Bioline), generated a band at the same size as the expected 
amplicon and matched band amplified in the E. coli controls in lanes 2, 3 and 
4. This band was missing in the negative controls amplified with the ultra-
clean Moltaq polymerase.  
 
 
Figure 10-4: Bacterial contamination in Taq polymerase. 
20µl of amplified library was visualised on 2% agarose SYBR Safe E-Gels (Invitrogen). 
Lanes 2, 3 and 4 in both gels contain a serial dilution of a known concentration of E. coli. 
Negative controls in lanes 6 and 7 contained 5µl of PCR-grade water. KAPA Hifi Taq lane 5: 
50bp ladder and on the Moltaq gel lane 5: 100bp ladder. 16S rDNA amplicons in both gels 
appeared at ~500bp. 
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To reduce the number of errors introduced into the dataset during the PCR, I 
reduced the number of PCR cycles. A reduction in the number of cycles from 
36 to 34, following the addition of 2µl template into a 25µl reaction, resulted 
in a 10-fold reduction in the sensitivity of the PCR (Figure 10-5). 
 
 
 
Figure 10-5: Comparison of lowering cycle number on sequencing 
library generation. 
20µl of amplified library was visualised on 2% agarose SYBR Safe E-Gels. EC = positive 
control E. coli DNA. 34 or 36 = 34 cycles or 36 cycles of PCR respectively.  Expected 
amplicon size was observed at ~500bp on a 50bp ladder. 
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However, by increasing the volume of template added to the reaction I was 
able to reduce the number of PCR cycles whilst retaining the original 
sensitivity of the PCR. Figure 10-6 shows in lanes 11 and 12 of the first gel, 
that successful amplification of E. coli was possible once volume of template 
added to the reaction was increased to 5µl using 30 PCR cycles. However 
when amplifying the lowest diluted concentration in E. coli (right hand gel, 
lane 2) only elucidated a very weak band compared to when amplified by 32 
cycles (left hand gel, lane 7).  When 2µl of E. coli template was added and 
amplified for 30 cycles, no band could be seen on the gel (left hand gel, lanes 
8, 9 and 10). 
 
 
 
Figure 10-6: Comparison of template volume and cycle number on 
library preparation. 
20µl of amplified library was visualised on 2% agarose SYBR Safe E-Gels. 2 or 5 EC = 
Either 2µl or 5µl of 1/10 serial dilutions of E. coli DNA for each combination of loading 
volume and cycle number. From left to right: EC 10
-2
, EC 10
-3
 and EC 10
-4
. 30 or 32 = 30 
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cycles or 32 cycles of PCR respectively.  Expected amplicon size was ~500bp on a 50bp 
ladder. 
 
 
 
10.3.3 Bacterial contamination of oligonucleotide primers 
when sequencing low biomass samples 
 
After preliminary analysis of the first 384 samples sequenced I found that the 
predominate organism recovered from the high-throughput sequencing data 
was an unknown Sphingomonas species (Figure 10-7). 
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Figure 10-7: Relative abundance of a Sphingomonas sp. across 384 placental tissue samples. 
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I tested for the possibility of reagent contamination and when I used the 
sequencing primers as template in the library preparation reaction I found 
that I could detect amplicon at the same size as our expected 16S rDNA 
product (Figure 10-8Figure 10-8). Sanger sequencing of the PCR product 
produced was used to confirm whether it was the same organism identified 
after high-throughput sequencing on the MiSeq and a BLAST search of the 
Sanger sequencing product also matched it to an uncultured Sphingomonas 
sp. New lyophilised oligonucleotide primers from a different source were also 
tested for the same contamination and were found to be free of detectable 
bacterial DNA. These primers were taken forward to be used in all future 
library preparations. 
 
 
Figure 10-8: Amplification of bacterial DNA contamination found in 
diluted oligonucleotides.  
20µl of amplified library was visualised on 2% agarose. Lane 2 contained amplified product 
from 5µl PCR grade water and lane 3 contained amplified product from 5µl E.coli DNA. 
Lanes 4-11 contained amplified product from 5µl of an randomly selected individual 
oligonucleotide used for library preparation.  Expected amplicon size was ~500bp on a 50bp 
ladder. 
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10.3.4 Development of a concise custom 16S database and 
rigorous filtering recreates artificial mock communities 
To validate the specificity and sensitivity of my 16S rDNA high-throughput 
sequencing wet lab and dry lab protocols, I sequenced mixtures of known 
concentrations of genomic DNA from a number of different bacteria in an 
attempt to describe the exact microbial community present. I used a ten 
member mock community kindly provided by the Jim Hugget at LGC, 
Teddington, UK (Table 10-1).  
 
Table 10-1: Ten member mixed bacterial mock community with known 
relative abundances 
 
Bacterial species  
16S rRNA gene copy number adjusted 
relative abundance (%) 
Neisseria meningitides 28.60 
Streptococcus pneumoniae 25.83 
Klebsiella pneumonia 20.24 
Staphylococcus aureus 12.74 
Streptococcus pyogenes 7.26 
Streptococcus agalactiae 2.72 
Escherichia coli 1.50 
Enterococcus faecalis 0.67 
Pseudmonas aeruiginosa 0.36 
Acinetobacter baumanii 0.07 
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I sequenced the mock community in triplicate on a single MiSeq run and after 
quality filtering I obtained 244,009, 21,671 and 19,705 high quality reads in 
each sample. After picking Operational Taxonomic Units at 97% sequence 
identity against either the Greengenes database or SILVA database, I found 
a large amount of read artefacts and erroneous assignment of taxonomy 
leading to an inflation of richness and phylogenetic diversity as sequencing 
depth increased. Figure 10-9 shows even though there was only a single 
Neisseria species in the sample, read error contributed to five separate OTU 
bins being assigned Neisseria or Neisseriaceae taxonomy. This included one 
OTU that clustered with Streptococcus spp. rather than in the Neisseria 
clade. Similar separations of clades due to error were also seen in both 
OTUs assigned to either Streptococcus or Staphylococcus genera. I also 
found at least one example of an erroneous sequence included in the 
Greengenes database that led to a sequence that was later shown to have 
99% similarity to Streptococcus pneumoniae being clustered as a separate 
OTU identified as an uncultured member of the Caulobacteraceae family. 
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Figure 10-9: Phylogenetic tree of the most abundant 28 OTUs after sequencing a known mock community. 
Phylogenetic analyses of ~370 bp OTUs with taxonomy assigned by RDP classifier. Colours highlight similar taxa that have been clustered 
on separate branches based on nucleotide differences. 
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I filtered the SILVA SSU Ref NR 111 database from 597,607 full length 16S 
rDNA sequences to 5,493 sequences. I kept only high quality sequences that 
had species identification and were from phyla previously found in our 
dataset after taxonomy assignment against the full Greengenes database. In 
most cases I limited the database to one full length sequence per species. 
When assigning global OTUs, I would first pick against the smaller, curated 
custom database and would pass any sequences that failed to match at 97% 
similarity through a second round of OTU picking against the full Greengenes 
database. 
An unfiltered dataset with OTUs assigned through the default workflow in 
QIIME found 166 unique OTUs in the 20 species mixed mock community 
(Table 10-2). This included all the known community members as well as 69 
OTUs whose taxa did not match any in the mock community. The most 
inflated OTU counts in actual mock community genera were Streptococcus 
(26 unique OTUs compared to 3 species) and Staphylococcus (24 OTUs 
compared to 1 species). Using the two rounds of OTU picking against our 
custom database and modest filtering of the dataset, removing all OTUs 
found at 0.07% abundance in the sample and below, I removed a vast 
majority of spurious OTUs (Table 10-2). The value 0.07% was chosen as it 
was the most abundant OTU from a taxonomic lineage that I knew was not 
present in the mock community. 
Using the same OTU table, I performed a further rigorous filtering step that 
removed the erroneous Neisseria, Streptococcus and Staphylococcus OTUs 
identified after multiple pairwise alignments in Figure 10-9. This led to all 
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OTUs present at 1% relative abundance and below in the sample removed. 
While this recreated an ideal OTU-to-species ratio for many of the mock 
community members it also meant three of the lower abundance organisms 
were filtered out from the dataset entirely (Table 10-2). 
 
 
Table 10-2: Comparison of database and filtering effects on mock 
community members  
 
 
Unfiltered, 
Greengenes 
database 
Contaminating 
bacteria filtered 
(0.07%), custom 
database 
Major alignment 
errors filtered 
(1%), custom 
database 
Overall number of OTUs 166 29 13 
Neisseria meningitides 8 2 2 
Streptococcus pneumoniae 21 6 1 
Klebsiella pneumonia 8 6 4 
Staphylococcus aureus 24 6 2 
Streptococcus pyogenes 4 2 2 
Streptococcus agalactiae 1 1 1 
Escherichia coli 6 1 1 
Enterococcus faecalis 14 2 0 
Pseudmonas aeruiginosa 7 1 0 
Acinetobacter baumanii 5 1 0 
Other 68 0 0 
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10.4 Discussion 
A successful method for the characterisation of microbiota across multiple 
body sites has been designed and optimised and can now be applied to the 
samples collected in this study. Likely sources of reagent contamination have 
been identified and removed and methods formulated to filter out external 
PCR and sequencing errors from  the dataset. 
In this study I compared three primer sets that covered 16S rRNA gene 
hypervariable regions V1-V2 (8F/3R), V4 (515F/806R) and V5-V7 
(785F/1175R). Much of the variance seen in a microbiome study can be due 
to the particular human, animal or environmental site studied as well as the 
technology employed to capture, amplify and sequence DNA. However 
choosing which of the target variable regions of the 16S rDNA gene to 
amplify is an important contributing factor (105). Liu et al reported that 
primers covering the V2 and V3 regions performed much better than V6 in 
taxonomic assignment and community clustering (125). Although I compared 
similar variable regions, in this study, I merged larger amplicons from 
overlapping paired-end reads, encompassing multiple variable regions, which 
could explain why the V5-V7 amplicon in this study yielded the best results. 
Soergel et al proposed a primer pair amplifying a smaller read length from 
the V4 provided similar coverage to longer reads from other areas of the 
gene for comparing shifts at the phylum level (105). However phylum level 
shifts are not always useful and species level identification is ideal in many 
studies. The microbiome of placental and fetal tissue does not have the same 
static, complex microbiome found in other sites, for example the gut and so 
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large scale comparisons of shift in bacteria phyla is unlikely to be as useful in 
determining underlying problems. In silico comparisons have been used to 
evaluate primer pairs (106,107) and although this kind of computational 
modelling can identify obvious shortcomings of certain methods, it can be 
difficult to translate these findings to those of the more complex 
representative human body sites. There are limitations in every broad-range 
primer pair chosen and so screening of potential candidates for your study 
question against “real world” examples is a key advantage (106). I found 
primers covering the V5-V7 hypervariable region could easily be integrated 
into a workflow on the MiSeq platform and provided better coverage for our 
specific samples when compared to the two other primer pairs in this study. 
Reagent contamination is now beginning to be recognised as a large 
confounding factor in microbiome studies (126). In a study by Salter et al, 
they showed that as the bacterial biomass used as input for your library 
preparation reduced, the relative amount and diversity of reagent 
contamination increased (84). In their example they used serial dilutions of 
known quantities of Salmonella bongori to demonstrate this, however I show 
similar results when sequencing 16S rDNA from placental tissue. The 
amount of bacterial DNA extracted from the placenta can vary greatly which 
leaves ample opportunity in some samples to amplify 16S rDNA 
contamination found in laboratory reagents. In our case it was widespread 
presence of a Sphingomonas sp. in the diluted forward and reverse 
oligonucleotide primers was the most significant contamination faced. This is 
due to the fact that primers can be shipped with contaminating bacterial DNA 
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due to improper sterilisation during the manufacturing process. There have 
been other published cases of Sphingomonas spp. contamination in 16S 
rDNA studies (127,128) probably because this organism is a recognised as a 
contaminant of ultra-pure water systems in the manufacturing industry (129). 
Due to the lower levels of contamination observed in lyophilised primers 
supplied by the same company it is likely that water used during 
oligonucleotide synthesis was the source.   
The number of PCR cycles has long been recognised as a source of bias 
and can lead to inflation of unique 16S rDNA sequences in bacterial studies. 
In a comparison between 35 and 18 amplification cycles, an increase in the 
percentage of chimeric sequences was seen at 35 cycles (130). A later 
similar study found 30% more chimeric samples within their dataset when 
comparing amplification at 30 cycles to 15 cycles (114). Unfortunately, 
reduction of PCR cycle also leads to reduction in the amount of PCR product 
recovered. In this study I have tried to strike a balance between lowering 
PCR cycles but still keeping sensitivity high enough to identify genuine 
bacterial colonisation of placental tissue. Instead I have focused on the use 
of ultra-pure reagents (Moltaq) and a number of methods to try and reduce 
the numbers of erroneous reads post-sequencing, including clustering OTUs 
and extensive quality filtering (115,131). 
Other considerations to take into account when trying to improve the 
accuracy and reproducibility of high-throughput sequencing data are the 
quality of the reads produced and the reference database used. Generally 
the MiSeq can produce millions of high quality reads but the accuracy of 
66 
 
Illumina reads increases from 85% to 99.65% when overlapping paired-end 
reads are used instead of single-end (132). There are also a host of 
documented advantages using the current Greengenes database as a 
training set due to it being largest available repository of curated full length 
16S rDNA gene sequences. Trimming this reference database to match a 
specific amplicon length has also been shown to increase confidence in 
taxonomic assignment (116). I have chosen to pursue an additional strategy 
that is the curation of a site-specific reference database, which has been 
previously described for a set of oral microbiome data (133). It is common for 
16S databases to have large numbers of unidentified and poorly annotated 
sequences and this leads to poor taxonomic assignment. Instead, a site-
specific 16S rDNA database can be curated and updated and as more 
samples are sequenced, the database becomes more accurate, as 
previously shown by the Vaginal Human Microbiome Project (117). 
The sequencing technique has been designed and optimised and can now 
be applied to the study samples using larger multiplexed MiSeq runs. 
Jackknifed bootstrapping analysis of the data already collected showed that 
1,000 sequences per sample provided enough depth to recover all the 
diversity in the sample. This means there is the potential to multiplex 500 
samples on a single MiSeq run and still be confident the results are accurate 
and reproducible. Also, as improvements to sequencing methods and 
downstream processing of data are regularly published (119,134) they should 
lead to even more reproducible and reliable results from microbiome studies.  
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11 Chapter 4: Effect of the Lipid-based nutritional 
supplement on placental, oral and vaginal 
microbiota. 
 
11.1 Introduction 
Nutritional status is a key health determinant, especially during pregnancy. 
The prevalence of women with low BMI in Africa is still 10% higher than in 
high-income countries (9) and maternal nutritional deficits such as anaemia, 
vitamin A deficiency  or zinc deficiency during pregnancy can lead to higher 
incidence of maternal and newborn morbidity and mortality (135–137). 
Southern Africa has the second highest prevalence of low birth weight and 
among the highest proportions of stunted, wasted and underweight mothers 
and neonates (9). Micronutrient supplementation has been used in the 
attempt to supplement poor diet in low-income countries during pregnancy to 
improve duration of pregnancy and newborn size. A meta-analysis of these 
studies found that multiple micronutrients (MMN) had a small effect on birth 
weight but no effect on duration of pregnancy compared to iron and folic acid 
(IFA) supplementation (94).  
The iLiNS-DYAD-M trial set about to improve maternal and child health in 
rural Malawi with the addition of Lipid-based nutrient supplement (LNS) to a 
pregnant mother’s and newborn child’s diet. A previous systematic review 
found that additional protein and energy, as well as micronutrients, could 
reduce intrauterine growth restriction (138). The only previous LNS trial 
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before iLiNS-DYAD-M that studied the impact of LNS during pregnancy found 
that it increased mean birth length compared to MMN supplementation (139). 
iLiNS-DYAD-M trial results were published in 2015 and found that the 
provision of LNS did not have any statistically significant effect on low birth 
weight, newborn stunting or newborn small head circumference (88). Despite 
these results, the change to the diet of these participants could still affect 
predictors and outcomes used in this thesis. 
The effect of nutrition and diet on the microbiome is well established. 
Microbial composition of the gut has now been associated with obesity, with 
reduced species richness and a change in phenotype that increases energy 
extraction contributing to weight gain (140,141). Gut microbiota have also 
been linked to the widespread problem of undernutrition (142) and in 
malnourished children there are consistent, long-term changes in community 
structure (143). A study in Kenya in 2014 even found that a micronutrient 
supplement, specifically iron, could be adversely altering infant’s gut 
microbiota (144). Due to the action of malnutrition on the immune system 
(145), it is also plausible that diet and nutritional supplementation could have 
an effect on other human microbiomes. The vaginal microbiome has been 
shown to be altered by increased fat, folate, vitamin E and calcium intake that 
can increase the prevalence of pathogenic bacteria associated with bacterial 
vaginosis (146). In the mouth, increased sugar consumption has long been 
linked to increased prevalence of dental caries and enamel erosion (147). In 
low income, tropical countries where malnutrition and other infections are rife, 
this can affect the efficiency of saliva as an immune barrier, substantially 
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changing the microbiota found in the mouth and possibly causing acute 
necrotising gingivitis (148). One recent study has looked at the specific action 
of a diet supplement on a rural sub-Saharan African population but found 
while there were changes in the gut microbiota, there was little difference 
found in both the oral and vaginal microbiomes (149). 
I wanted to study the potential impact the nutritional intervention an individual 
received on their multiple microbiomes. I wanted to quantify any effects so 
they could be taken into account later when comparing the possible role of 
the microbiome has in association with birth outcomes. Secondly, if there 
was an effect, it would be possible to study the possibility of using nutritional 
interventions in positively altering microbial community structures in the 
placenta, mouth or vagina.  
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11.2 Materials and Methods 
 
11.2.1 Study design and enrolment 
See section 9.1. Full details on the design, nutrient and energy contents of 
each dietary supplement in the trial can be found in the publication of the 
primary outcomes (88). 
 
11.2.2 Study setting 
See section 9.2 
 
11.2.3 Collection of birth outcome and baseline data 
See section 9.3 
 
11.2.4 Sample collection 
See section 9.4 
 
11.2.5 DNA Extraction 
See section 9.5 
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11.2.6 16S rDNA broad-range qPCR 
See section 9.6 
 
11.2.7 16S rDNA amplicon high-throughput sequencing 
See section 9.7 
 
11.2.8 Bioinformatics and statistical analysis 
Downstream processing of all FASTQ reads collected from placenta, fetal 
membrane, vaginal and oral samples was carried out as stipulated in section 
9.8.  
Three separate variables were used to measure changes in microbiota found 
in the placenta and fetal membranes. Prevalence of bacteria in the placenta 
and fetal membrane was defined as detectable presence of 16S rDNA in a 
sample of placenta or fetal membrane tissue from a participant. I also 
analysed the amount of 16S rDNA present in the tissue as representative of 
the bacterial load. To represent how bacterial community structure changes 
between the different arms of the study I calculated the median intra-
individual unweighted UniFrac distance for each individual from pairwise 
comparisons between all individuals. A higher median UniFrac distance 
represented a different subset of microbiota in that individual compared to all 
others. The lower the UniFrac distance, the more similar that participant’s 
microbiota was to other participants. To represent bacterial species richness I 
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calculated the number of unique OTUs present for each intervention arm in 
each site. For the oral and vaginal microbiome I only reported UniFrac 
distances and observed number of OTUs. 
I carried out the statistical analysis with Stata 13 (StataCorp, College Station, 
USA). I conducted the statistical analysis according to the analysis plan 
written and published before the intervention code was opened. I based the 
analysis on the principle of intention-to-treat. The intervention code was 
broken after the analysis. The global null hypothesis was tested between 
intervention groups using Fishers exact test for binary outcomes and one-
way ANOVA for continuous outcomes. If either test was significant, pairwise 
comparisons were then carried out between all intervention groups. All 
analyses were also adjusted using multivariate models to correct for possible 
confounding effects, all variables picked for testing in the models were 
chosen based on previous literature as logically capable of forming an 
independent interaction with the outcome being measured. All covariates 
were then entered in a single step into the equation. Continuous outcomes 
were modelled using linear regression and binary outcomes were modelled 
using log-binomial regression. I tested variables predefined in the analysis 
plan as effect modifiers using the likelihood ratio tests for interaction between 
the intervention and maternal characteristics. Maternal variables tested were 
age, BMI at enrolment, number of previous pregnancies, anaemia, HIV and 
malaria status at enrolment, education (completed years), socio-economic 
status and study site of enrolment.  Stratified analysis was then produced for 
any effect modifiers that were statistically significant.  
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11.3 Results 
 
11.3.1 Sample collection and baseline characteristics by 
intervention group 
I did not have a predefined hypothesis concerning the effect of LNS on 
participant’s resident microbiomes at inception. However, I was still 
interested in any potential impact on the microbiome and postulated that LNS 
might change the prevalence and amount of bacteria recovered from the 
placenta and fetal membranes and the diversity of bacteria found in the oral 
cavity and vagina.  
Of the 1391 participants recruited into the iLiNS-DYAD-M trial, a sample of 
placenta was collected at delivery from 1030 (73.3 %) participants and a 
sample from the fetal membranes was collected from 1095 (78.7 %) 
participants. For DNA analysis, after excluding twin deliveries, this left 1018 
(73.2 %) participants with a placenta sample analysed, with 347, 335 and 
336 in the IFA, MMN and LNS groups respectively. Loss to follow up was 
similar in all of the supplement groups (p=0.535). It also left 1083 (77.9 %) 
participants with fetal membrane samples analysed with a breakdown of 358, 
364 and 361 in the IFA, MMN and LNS groups respectively. Loss to follow up 
was similar in all of the supplement groups (p=0.811). An oral and vaginal 
swab was also collected from each participant one week after delivery. After 
excluding twin deliveries and any samples that did not produce enough reads 
after sequencing, 1104 (79.4 %) oral swabs and 1107 (79.5 %) vaginal 
swabs were included in the analysis. Of the 1104 participants with an oral 
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swab collected, 374 were in the IFA, 374 in MMN and 356 in LNS groups. 
Loss to follow up was similar in all of the supplement groups (p=0.531). For 
participants with a vaginal swab collected there were 370, 371 and 366 in the 
IFA, MMN and LNS groups respectively. Loss to follow up was similar in all of 
the supplement groups (p=0.952). 
Across study arms, all participants with a vaginal swab sample taken had 
similar health status, demographic and socioeconomic characteristics at 
enrolment (p>0.05) (Table 11-1). 
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Table 11-1: Baseline characteristics of participants at enrolment by intervention group  
 
Characteristic IFA MMN LNS P value
b 
Number of participants (n=1107
a
) 370 371 366 - 
Mean (SD) BMI, kg/m² 22.1 (2.6) 22.1 (3.0) 22.1 (2.8) 0.908 
Mean (SD) maternal age, years 25 (5.9) 25 (5.9) 25 (6.2) 0.824 
Mean (SD) maternal education, completed years at 
school 
3.9 (3.4) 3.9 (3.4) 4.0 (3.5) 0.809 
Mean (SD) proxy for socioeconomic status -0.08 (0.9) -0.04 (0.9) -0.03 (0.9) 0.817 
Proportion of anaemic women (Hb < 100 g/l) 21.6 % 18.1 % 20.2 % 0.480 
Proportion of primiparous women  19.7 % 20.8 % 19.7 % 0.916 
Proportion of women with a low BMI (<18.5 kg/m²)  5.4 % 5.5 % 6.3 % 0.860 
Proportion of women with a positive HIV test 16.0 % 10.9 % 14.8 % 0.097 
Proportion of women with a positive malaria test 
(RDT) 
21.9 % 24.6 % 23.8 % 0.699 
a 
Those participants that had a section of placental tissue taken after delivery and were processed for DNA extraction and sequencing. 
b 
P-value obtained from ANOVA (comparison of means) or Fishers exact test (comparison of proportions) .
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11.3.2 Association between placental and fetal membrane 
bacterial load, prevalence and nutritional intervention 
From participants included in all intervention arms, bacteria were identified in 
46.8 % (n=476) of participants’ placental tissue and 64.8 % (n=654) of fetal 
membranes. The mean (SD) bacterial load was 4.8 (0.7) Log10 16S rDNA 
copies/µl in the placental tissue and 5.2 (0.8) Log10 16S rDNA copies/µl in 
fetal membranes. Bacterial load had a J-shaped distribution in both the 
placenta and the fetal membranes with most tissues having very low bacterial 
loads. 
Analysis of bacterial load in the placenta and fetal membranes by 
intervention group showed an association in the unadjusted values with the 
bacterial load in the placenta being lower in the LNS group (Table 11-2). The 
difference in means (95% CI) was -0.17 (-0.31, -0.02) between the LNS and 
IFA groups (p=0.023) and -0.21 (-0.35, -0.06) between the LNS and MMN 
groups (p=0.006). This difference was also seen in the adjusted model at the 
global level and between the LNS and MMN groups, but not between the 
LNS and IFA groups. There were no differences seen in the presence of 16S 
rDNA among individuals in the different groups (Table 11-3). 
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Table 11-2: Bacterial load in the placenta and fetal membranes by intervention group 
 
 Result by study group 
Comparison between LNS 
and IFA group 
Comparison between LNS 
and MMN group 
Comparison between 
MMN and IFA group 
Outcome IFA MMN LNS 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Mean (SD) bacterial load in the 
placenta (Log10 16S rDNA 
copies/µl)
 1
 
4.85 
(0.7) 
4.89 
(0.7) 
4.68 
(0.6) 
0.014 
-0.17 (-0.31, -
0.02) 
0.023 
-0.21 (-0.35, -
0.06) 
0.006 
0.04 (-0.10, 
0.18) 
0.583 
Placenta bacterial load 
comparison adjusted model
 3
 
   0.049 
-0.14 (-0.28, 
0.01) 
0.071 
-0.18 (-0.34, -
0.03) 
0.019 
0.05 (-0.10, 
0.20) 
0.536 
           
Mean (SD) bacterial load in the 
fetal membrane (Log10 16S 
rDNA copies/µl)
 2
 
5.21 
(0.8) 
5.22 
(0.9) 
5.24 
(0.8) 
0.896 
0.03 (-0.12, 
0.17) 
0.736 
0.03 (-0.12, 
0.19) 
0.650 
0.01 (-0.14, 
0.16) 
0.901 
Fetal membrane bacterial load 
comparison adjusted model
 3
 
   0.761 
0.04 (-0.11, 
0.19) 
0.588 
0.05 (-0.09, 
0.20) 
0.478 
-0.01 (-0.16, 
0.13) 
0.865 
           
1 
IFA n=168, MMN n=151, LNS n =157
 
2
 IFA n=247, MMN n=260, LNS n =231 
3
 Model was adjusted for mother’s height at enrolment, mother’s age at enrolment, BMI, HIV, primiparity, anaemia, malaria status at enrolment, completed years in education, 
socio-economic status, study site, time between delivery and collection of placenta sample, caesarean sections and season at enrolment. Covariates were chosen in a 
predefined analysis plan on the logical potential to form an association with one of the outcomes based on previous literature.  
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Table 11-3: Prevalence of bacteria in the placenta and fetal membranes by intervention group 
 
 Result by study group 
Comparison between 
LNS and IFA group 
Comparison between 
LNS and MMN group 
Comparison between 
MMN and IFA group 
Outcome IFA MMN LNS 
P 
value 
Risk ratio 
(95 % CI) 
P 
value 
Risk ratio 
(95 % CI) 
P 
value 
Risk ratio 
(95 % CI) 
P 
value 
Bacteria in the placenta
1
 
157 
(46.7%) 
151 
(45.1%) 
168 
(48.4%) 
0.683 
1.03 (0.89, 
1.21) 
0.659 
0.96 (0.82, 
1.13) 
0.668 
1.07 (0.91, 
1.26) 
0.383 
Bacteria in the placenta 
comparison adjusted model
 3
 
   0.400 
1.02 (0.87, 
1.19) 
0.821 
0.92 (0.78, 
1.08) 
0.298 
1.11 (0.95, 
1.30) 
0.198 
           
Bacteria in  the fetal 
membrane
2
 
247 
(68.9%) 
260 
(71.4%) 
231 
(63.9%) 
0.094 
1.08 (0.97, 
1.19) 
0.156 
1.12 (1.01, 
1.23) 
0.033 
0.97 (0.88, 
1.06) 
0.475 
Bacteria in the fetal 
membranes comparison 
adjusted model
 3
 
   0.112 
1.07 (0.96, 
1.19) 
0.233 
1.11 (1.01, 
1.23) 
0.037 
0.96 (0.87, 
1.05) 
0.363 
           
1 
IFA n=347, MMN n=335, LNS n =336
 
2
 IFA n=358, MMN n=364, LNS n =361
 
3
Model was adjusted for mother’s height at enrolment, mother’s age at enrolment, BMI, HIV, primiparity, anaemia, malaria status at enrolment, completed years in education, 
socio-economic status, study site, time between delivery and collection of placenta sample, caesarean sections and season at enrolment. Covariates were chosen in a 
predefined analysis plan on the logical potential to form an association with one of the outcomes based on previous literature.  
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11.3.3 Association between placental, fetal membrane, oral 
and vaginal beta diversity and nutritional intervention 
Table 11-4 and Table 11-5 show the analysis between bacterial diversity in 
placenta, fetal membranes, oral cavity and vagina. Phylogenetic diversity 
was measured using the unweighted UniFrac distance based on pairwise 
comparisons between all samples. A single value per participant was 
generated by taking the median distance value from all comparisons. A 
higher distance value would suggest that an individual’s microbiome had 
phylogenetically dissimilar organisms to the rest of the cohort and a lower 
value would suggest the opposite. When the values were grouped by 
intervention arm there were no statistically significant differences seen at the 
global level in either the unadjusted values or the adjusted models. 
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Table 11-4: Bacterial diversity in the placenta and fetal membranes by intervention group 
 
 Result by study group 
Comparison between 
LNS and IFA group 
Comparison between 
LNS and MMN group 
Comparison between 
MMN and IFA group 
Outcome IFA MMN LNS 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Mean (SD) intra-individual 
unweighted UniFrac distance in 
placental tissue
 1
 
0.69 
(0.1) 
0.69 
(0.1) 
0.69 
(0.1) 
0.869 
0.00 (-0.01, 
0.02) 
0.627 
0.00 (-0.01, 
0.01) 
0.947 
0.00 (-0.01, 
0.01) 
0.680 
Placenta unweighted UniFrac 
distance comparison adjusted 
model
 3
 
   0.872 
0.00 (-0.01, 
0.02) 
0.700 
0.00 (-0.01, 
0.01) 
0.903 
0.00 (-0.01, 
0.02) 
0.620 
           
Mean (SD) intra-individual 
unweighted UniFrac distance in 
fetal membranes
2
 
0.72 
(0.1) 
0.72 
(0.1) 
0.71 
(0.1) 
0.156 
-0.01 (-0.02, 
0.00) 
0.141 
-0.01 (-0.02, 
0.00) 
0.067 
0.00 (-0.01, 
0.01) 
0.730 
Fetal membrane unweighted 
UniFrac distance comparison 
adjusted model
 3
 
   0.219 
-0.01 (-0.02, 
0.00) 
0.136 
-0.01 (-0.02, 
0.00) 
0.124 
0.00 (-0.01, 
0.01) 
0.962 
           
1 
IFA n=167, MMN n=150, LNS n =157
 
2
 IFA n=247, MMN n=260, LNS n =231 
3
 Model was adjusted for mother’s height at enrolment, mother’s age at enrolment, BMI, HIV, primiparity, anaemia, malaria status at enrolment, completed years in education, 
socio-economic status, study site, time between delivery and collection of placenta sample, caesarean sections and season at enrolment. Covariates were chosen in a 
predefined analysis plan on the logical potential to form an association with one of the outcomes based on previous literature.  
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Table 11-5: Bacterial diversity in the oral cavity and vagina by intervention group 
 
 Result by study group 
Comparison between 
LNS and IFA group 
Comparison between 
LNS and MMN group 
Comparison between 
MMN and IFA group 
Outcome IFA MMN LNS 
P 
value 
Difference in 
means (95 
% CI) 
P 
value 
Difference in 
means (95 
% CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Mean (SD) intra-individual 
unweighted UniFrac distance in 
the oral cavity
1
 
0.49 
(0.1) 
0.49 
(0.1) 
0.51 
(0.1) 
0.342 
0.01 (-0.01, 
0.02) 
0.347 
0.01 (-0.01, 
0.02) 
0.148 
0.00 (-0.02, 
0.01) 
0.609 
Oral cavity unweighted UniFrac 
distance comparison adjusted 
model
 3
 
   0.326 
0.01 (-0.01, 
0.02) 
0.366 
0.01 (-0.00, 
0.02) 
0.137 
0.00 (-0.02, 
0.01) 
0.553 
           
Mean (SD) intra-individual 
unweighted UniFrac distance in 
the vagina 
0.59 
(0.1) 
0.59 
(0.1) 
0.60 
(0.1) 
0.510 
0.01 (-0.01, 
0.02) 
0.295 
0.00 (-0.02, 
0.02) 
0.923 
0.01 (-0.01, 
0.02) 
0.340 
Vaginal unweighted UniFrac 
distance comparison adjusted 
model
 3
 
   0.438 
0.01 (-0.01, 
0.03) 
0.264 
0.00 (-0.02, 
0.02) 
0.990 
0.01 (-0.01, 
0.03) 
0.270 
           
1 IFA n=370, MMN n=371, LNS n =366 
2 IFA n=374, MMN n=374, LNS n =356 
3 Model was adjusted for mother’s height at enrolment, mother’s age at enrolment, BMI, HIV, primiparity, anaemia, malaria sta tus at enrolment, completed years in education, 
socio-economic status, study site, time between delivery and collection of placenta sample, caesarean sections and season at enrolment. Covariates were chosen in a 
predefined analysis plan on the logical potential to form an association with one of the outcomes based on previous literature.  
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11.3.4 Association between placental inflammation and 
nutritional intervention 
Prevalence of intervillositis across all participants included in the analysis 
was 17.5 % (n=176). Chorioamnionitis was recorded in 26.1 % (n=258) of 
participants whereas 12.1 % (n=120) of participants had severe 
chorioamnionitis. Table 11-6 shows the analyses between intervillositis and 
chorioamnionitis across different nutritional interventions. There were no 
statistically significant differences between intervention groups for these 
variables at the global level in either the unadjusted values or the adjusted 
models. 
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Table 11-6: Inflammation in the placenta by intervention group 
  
Comparison between 
LNS and IFA group 
Comparison between 
LNS and MMN group 
Comparison between 
MMN and IFA group 
Outcome IFA 
(n=330)
 
MMN 
(n=333)
 
LNS 
(n=345)
 
P 
value 
Risk ratio 
(95 % CI) 
P 
value 
Risk ratio 
(95 % CI) 
P 
value 
Risk ratio 
(95 % CI) 
P 
value 
Intervillositis
1 
 
54 
(16.4%) 
64 
(19.2%) 
58 
(16.8%) 
0.580 
0.97 
(0.69 to 1.58) 
0.876 
1.14 
(0.83 to 1.58) 
0.415 
0.85 
(0.61 to 1.18) 
0.337 
Intervillositis, adjusted 
model
2 
 
   0.264 
0.97 
(0.68 to 1.38) 
0.858 
1.25 
(0.89 to 1.25) 
0.195 
0.78 
(0.55 to 1.09) 
0.144 
Chorioamnionitis
1 
 
89 
(27.3%) 
85 
(26.1%) 
84 
(24.9%) 
0.180 
1.09 
(0.85 to 1.42) 
0.473 
1.05 
(0.81 to 1.36) 
0.718 
1.05 
(0.81 to 1.35) 
0.723 
Chorioamnionitis, 
adjusted model
2 
 
   0.486 
1.17 
(0.89 to 1.52) 
0.245 
1.13 
(0.87 to 1.47) 
0.377 
1.04 
(0.71 to 1.17) 
0.772 
Severe chorioamnionitis
1 
 
45 
(13.8%) 
38 
(11.7%) 
37 
(10.9%) 
0.511 
1.26 
(0.69 to 1.63) 
0.265 
1.06 
(0.69 to 1.63) 
0.773 
1.18 
(0.79 to 1.77) 
0.412 
Severe chorioamnionitis, 
adjusted model
2 
 
   0.476 
1.27 
(0.84 to 1.93) 
0.258 
1.05 
(0.67 to 1.63) 
0.842 
1.22 
(0.79 to 1.86) 
0.364 
1
 Unadjusted model. 
2
 Adjusted p-values were calculated using log-binomial regression models. Models were adjusted for covariates that had a significant association (p<0.10) with the outcome on 
bivariate analysis, in addition to the corresponding values at enrolment. All models were adjusted for mother’s height at enrolment, mother’s age at enrolment, BMI, HIV, 
primiparity, anaemia, malaria status at enrolment, completed years in education, socio-economic status, study site, time between delivery and collection of placenta sample and 
season at enrolment.
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11.3.5 Effect modifiers 
Maternal height, maternal BMI, gestational age at enrolment, maternal age, 
proxy for socioeconomic status, maternal education, primiparity, season at 
enrolment, maternal anaemia, malarial infection, enrolment site and maternal 
HIV status were all tested for interactions with the intervention, with respect 
to the microbiota. The variables were tested using the likelihood ratio test and 
were selected in a predefined analysis plan as likely to be able to modulate 
the effect of the nutritional intervention. Only whether the mother was 
primiparous or multiparous tested positive for effect modification with at least 
one outcome. 
Table 11-7 shows bacterial load by intervention group and stratified by 
whether the mother was primiparous or multiparous. The comparison had 
both a significant interaction with the intervention using the likelihood ratio 
test and had a global significant P value between the intervention groups in 
multiparous women. When stratified by parity, mothers who were multiparous 
had a lower bacterial load in the LNS group compared to the MMN group (-
0.24 (-0.39, -0.09), p=0.002) but not the IFA group. 
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Table 11-7: Effect modification by intervention group 
 
  
Result by study group 
Comparison between 
LNS and IFA group 
Comparison between LNS 
and MMN group 
Comparison between 
MMN and IFA group 
Outcome 
Interaction 
test P 
value
1
 
IFA  MMN LNS  
P 
value
2
 
Difference in 
means (95 % 
CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Difference in 
means (95 % 
CI) 
P 
value 
Placenta bacterial 
load, multiparous 
0.035 
4.8 
(0.6) 
4.9 
(0.7) 
4.7 
(0.5) 
0.010 
-0.12 (-0.27, 
0.03) 
0.127 
-0.24 (-0.39, -
0.09) 
0.002 
0.12 (-0.03, 
0.27) 
0.113 
            
1
 P values were calculated using likelihood-ratio test. 
2
 P values were calculated using ANOVA comparison of means.
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11.4 Discussion 
 
This study’s findings suggest that provision of LNS to pregnant women may 
have an impact on lowering bacteria load in full thickness placental samples 
when compared against the MMN group, especially in mothers that have 
delivered more than once. However the same result was not seen when 
compared to the IFA group or when comparing fetal membrane samples. 
There were no differences between intervention groups when compared to 
the presence of bacteria in the placenta and fetal membranes or bacterial 
diversity in the placenta, fetal membranes, oral cavity and the vagina. 
Inflammation associated with intrauterine infection can be harmful to the 
foetus. Low birth weight infants have been shown to have significantly higher 
levels of oxidative stress markers in their cord blood, when compared to 
those of a healthy weight (150). As well as injuring the foetus, reactive 
oxygen species can also damage the amniotic epithelium potentially leading 
to early delivery. However this effect has been mitigated in vitro after 
treatment with vitamins C and E. However even with the high levels of 
vitamin deficiency in Malawian diets, there were no statistical differences 
seen across the different intervention arms in birth outcomes (88) or 
chorioamnionitis. Although it did not translate into a quantifiable effect on 
birth outcomes, the lower bacterial load in the LNS group suggests a possible 
role for increased energy and fat intake in a rural Malawian diet in protecting 
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against bacterial proliferation in the placenta. However, this was not reflected 
in the ability to detect the presence of bacterial 16S rDNA. 
Comparative studies looking at the associations between nutrient intake, birth 
outcomes and the microbiome are scarce. A recent study in Tanzania looked 
at the effect of probiotic yoghurt with additional micronutrients on maternal 
vaginal, oral and faecal microbiota and its impact on birth outcomes, however 
it did not study the effect on placental microbiota (149). Similar to this study, 
they found very little effect on phylogenetic diversity could be explained by 
the nutritional supplement. Generally large scale shifts in taxa composition 
were explained by other influences. 
Although I found no difference in bacterial diversity in the oral microbiota, the 
ability to detect a difference could be influenced by the type of sample 
obtained in this study. A swab was used to rub the gingival margins, which 
would not pick up pathogenic bacteria found in deep periodontal pockets that 
could affect oral health and so I cannot rule out that these interventions had 
no effect. 
More complex analysis could be carried out on this dataset to track more 
minor shifts in community constituents if this was desired. For example, I 
know the effect that iron has on certain gut and vaginal taxa (144,151) and so 
I could look at the effect on abundance of OTUs known to utilise iron 
sources, rather than focusing on the entire community. The effect might also 
be more acute in at-risk populations, such as anaemic individuals. However, 
as I did not find any major shifts in multiple bacterial and inflammatory 
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variables across the intervention arms I have chosen to focus the subsequent 
result chapters in this thesis to studying their possible association with birth 
outcomes.  
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12 Chapter 5: The placental microbiome, its 
association with adverse birth outcomes and the 
potential source of intrauterine bacteria 
 
12.1 Introduction 
Sub-Saharan Africa has had consistently higher incidence of preterm 
deliveries (152) compared with the rest of the world, with recent estimates of 
between 10.0% (88) and 16.3% (153) of all births in Malawi. While the 
aetiology of spontaneous preterm labour remains elusive, a role for bacterial 
infection and colonisation of fetal membranes and the associated maternal 
inflammatory immune response is now recognized as the probable trigger in 
some cases. Spontaneous preterm birth (SPTB) is distinguished by a higher 
frequency of bacterial colonisation and by the nature and diversity of bacterial 
species (63). There is increasing evidence to suggest that it is the type of 
bacteria present in preterm deliveries, rather than simply the presence of 
bacteria, that differs from term deliveries (62,64,80). While bacteria can 
infect, and sometimes cross the placenta via the maternal circulation, in the 
majority of cases the common route of spread is through ascending infection 
from the vagina through the cervical canal (70). It appears that it is these 
bacteria that leads to inflammation of the chorioamniotic membranes 
(chorioamnionitis), well recognised as being highly associated with earlier 
delivery (70,154). 
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Whereas most studies to date have been conducted in Europe and North 
America, in this study I wanted to describe the core microbiome found in 
placental tissue and fetal membranes in a cohort of women in rural southern 
Malawi. I hypothesised that microbial community structure would be altered 
in participants with chorioamnionitis and those changes would be associated 
with duration of pregnancy, birth weight, newborn length and newborn head 
circumference.  
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12.2 Materials and Methods 
 
12.2.1 Study design and enrolment 
See section 9.1 
 
12.2.2 Study setting 
See section 9.2 
 
12.2.3 Collection of birth outcome and baseline data 
See section 9.3 
 
12.2.4 Sample collection 
Sample collection for genomic DNA extraction was carried out as stipulated 
in section 9.4. To examine for chorioamnionitis, one fetal membrane and one 
placenta were placed in 10% neutral buffered formalin fixative, processed 
and embedded in paraffin wax. These were sectioned at 3-5 micron thick and 
stained with haematoxylin & eosin before being read. 
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12.2.5 DNA Extraction 
In preparation for extraction of genomic DNA, each frozen tissue sample was 
cut into smaller pieces using a sterile pair of surgical scissors. 20-50mg of 
tissue was then transferred to a sterile 2ml screw-cap tube and extracted 
using same protocol as stipulated in section 9.5. 
 
12.2.6 16S rDNA broad-range qPCR 
See section 9.6. 
12.2.7 16S rDNA amplicon high-throughput sequencing 
Samples positive for bacterial DNA by qPCR were selected for sequencing. 
Sequencing was carried out as per protocol in section 9.7. 
 
12.2.8 Bioinformatics and statistical analysis 
See section 9.8. 
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12.3 Results 
 
12.3.1 Sample collection 
A total of 1391 participants were recruited into the iLiNS-DYAD-M trial and 
enrolment began in February 2011, with the last delivery taking place in 
February 2013. 1097 (78.9%) participants had at least one placental or fetal 
membrane tissue analysed for bacteria and histology. Figure 12-1 shows a 
flow diagram that documents reasons for the loss to follow-up of the 21.1% of 
participants who were not included in this microbiome study. Of these, 49 
were excluded because they had twins, a placental sample wasn’t collected 
or no histological result was obtained. 
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Figure 12-1: Study participant flow diagram. 
 
 
When the participants that were included in this study were compared to 
those excluded, those included had a lower BMI (22.1 vs 22.6 kg/m2, 
p=0.005), were older (25 vs 24 years, p=0.025), had completed less 
education (3.9 vs 4.7 years, p<0.001), had a lower score for socioeconomic 
status (-0.07 vs 0.36, p<0.001) and were less likely to be primiparous (20.4% 
vs 28.1%, p=0.006) (Table 12-1).  
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Table 12-1: Baseline characteristics of included and excluded 
participants 
Characteristic 
Included 
(n=1097)
1
 
Excluded 
(n=294) 
P 
value 
Mean (SD) BMI, kg/m
2
 22.1 (2.8) 22.6 (3.0) 0.005 
Mean (SD) maternal age, years 25.1 (6.1) 24.2 (6.3) 0.025 
Mean (SD) maternal education, completed years at 
school 
3.9 (3.4) 4.7 (3.8) <0.001 
Mean (SD) proxy for socioeconomic status -0.07 (0.9) 0.36 (1.2) <0.001 
Proportion of aenemic women (Hb < 110 g/l) 19.9 % 24.2 % 0.118 
Proportion of primiparous women 20.4 % 28.1 % 0.006 
Proportion of women with a low BMI (< 18.5 kg/m
2
) 5.6 % 4.7 % 0.656 
Proportion of women with a positive HIV test 13.3 % 15.0 % 0.469 
Number (%) of women with a positive malaria test 
(RDT) 
23.4 % 22.7 % 0.874 
1
Total n=1391 
2 
P value obtained from t-test (comparison of means) or Fishers exact test (comparison of proportions). 
 
 
12.3.2 Detection of bacterial DNA 
Bacteria were detected in 738 (68·1%) of fetal membranes and in 476 
(46·8%) of placental samples. Of those participants that had detectable 
bacteria the mean (SD) bacterial load was 5.22 (0.84) Log10 16S rDNA 
copies/µl in the fetal membranes and 4.80 (0.66) Log10 16S rDNA/µl copies in 
the placenta. The median sequencing depths for placental tissue and fetal 
membranes were 11,803 and 21,040 reads respectively (Table 12-2). 
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Table 12-2: Sequencing output. 
Sample type 
Number of 
samples 
Median number of reads per 
sample (IQR) 
Total number 
of reads 
Placental tissue 476 11,803 (3800,33561) 14,001,032 
Fetal membrane 738 21,040 (7340,54473) 30,941,823 
Total 1214  44,942,855 
 
 
12.3.3 The microbiome found in the placental tissues at 
delivery is distinct 
Figure 12-2 shows, across the population analysed, the 25 commonest 
organisms detected within placental tissues. Bacterial patterns were similar in 
fetal membranes and placental tissue. Fetal membranes had a higher 
incidence of Lactobacillus iners, Gardnerella vaginalis and Sneathia 
sanguinegens whereas the placental tissues had higher incidences of 
Acinetobacter spp. and Enterobacteriaceae spp.  
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Figure 12-2: Rank abundance curve. 
The 25 commonest organisms recovered from participants’ placental tissue (n=476) and fetal 
membranes (n=738). 
 
 
Comparing individuals, the bacteria detected within the placental and fetal 
membrane tissues were indistinguishable, suggesting in many cases a large 
overlap of similar taxa (Figure 12-3). Comparison of bacteria in placental and 
fetal tissues with bacteria in vaginal and oral samples from the same 
individuals revealed some overlap with the microbiota within the vagina, but 
very little overlap with the microbiota from the oral cavity (Figure 12-3). The 
placental and fetal membrane microbial communities had high variability 
when compared to the vaginal and oral microbiomes. Intra-individual 
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unweighted UniFrac distances in the placenta and fetal membranes were 
higher than the oral cavity and vagina. Placenta and fetal membranes had a 
mean (SD) UniFrac distance across all individuals of 0.69 (0.06) and 0.71 
(0.06) respectively, compared to 0.50 (0.09) in the oral cavity and 0.59 (0.11) 
in the vagina. 
 
 
99 
 
 
Figure 12-3: Principal component analysis of unweighted UniFrac 
distances computed for matched individual body sites. 
Distances computed from matched placenta (n=445), fetal membrane (n=719), oral 
(n=725) and vaginal (n=747) samples from 1107 participants. 
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12.3.4 Variation in the placenta microbiome is determined by 
abundance of a limited range of species 
Figure 12-4 and Figure 12-5 show that higher bacterial loads, as determined 
by qPCR, were observed when there were fewer OTUs, as determined by 
16S amplicon sequencing. In the placental tissue, a drop in observed OTUs 
of 1 was associated with a mean (95%CI) increase in bacterial load of 0·03 
(0·03, 0·04) log 10 16S rDNA copies / µl, p<0·001.  A decrease in observed 
OTUs of 1 in fetal membranes was associated with a mean (95%CI) increase 
in bacterial load of 0·04 (0·03, 0·05), p<0·001. This indicates that a high 
bacterial load is linked to the expansion of a limited number of organisms.  
However, the high median intra-individual unweighted UniFrac distances 
indicate that the composition of the microbial communities is highly variable 
between individual women.  Figure 3 demonstrates that a decrease in 
observed OTUs of 1 in placental tissue was associated with a rise of the 
mean (95%CI) intra-individual unweighted UniFrac distances of 0·02 (0·02, 
0·03), p<0·001 (Figure 3a). In fetal membranes a decrease in observed 
OTUs of 1 was associated with a rise of the mean intra-individual unweighted 
UniFrac distance of 0·03 (0·03, 0·04), p<0·001 (Figure 3b).  
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Figure 12-4: Multivariate plot of participant’s’ placental bacterial load, 
observed number of OTUs and median intra-individual unweighted 
UniFrac distances. 
102 
 
 
Figure 12-5: Multivariate plot of participant’s’ fetal membrane bacterial 
load, observed number of OTUs and median intra-individual 
unweighted UniFrac distances. 
 
 
12.3.5 Distinct combinations of bacteria associate with each 
other 
The placental microbial community structure was probed using the 
associations between the abundances of different OTUs. The abundances of 
a distinct group of phyla containing Fusobacteria, Tenericutes, Bacteroidetes 
and Actinobacteria were found to be positively correlated (Figure 12-6). 
Proteobacteria and Firmucutes were rarely found together and were 
negatively correlated with all other phyla.  
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Figure 12-6: Heat map of Spearman’s correlations between the 6 most 
abundant bacterial phyla in fetal membranes. 
Hierarchical clustering was computed by complete linkage of Euclidean distances. The heat 
map is annotated with mean difference in bacterial load between participants with and 
without severe chorioamnionitis for each bacterial phylum.  Asterisks indicate p<0·05 
association between higher load of that bacterial phylum and prevalence of severe 
chorioamnionitis. Adjusted model P values were calculated using linear regression adjusting 
for the nutritional intervention, maternal BMI at enrolment, maternal age, proxy for 
socioeconomic status, number of previous pregnancies, anaemia, site of enrolment, mode of 
delivery and time between delivery and placenta sampling. 
 
To explore these interactions in more detail I examined correlations among 
the 20 most abundant bacterial families and using hierarchical clustering this 
split the taxa into two major groups (Figure 12-7). One group, in which 
Fusobacteriaceae, Mycoplasmataceae, Bifidobacteriaceae, Prevotellaceae 
and Leptotrichiaceae abundances clustered together, matched the same 
correlations seen at the phyla level. However, the group also included many 
families from the Firmicutes phyla such as Clostridiaceae, Lachnospiraceae, 
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Lactobacillaceae and Peptostreptococcaceae. The second group of 
organisms that clustered together included a group of families from the phyla 
Firmicutes that included Streptococcaceae, Staphylococcaceae, 
Leuconostocaceae, Enterococcaceae and Lactobacillales, whose 
abundances were positively correlated with each other. The other organisms 
in that cluster were overwhelmingly from the phyla Proteobacteria and 
included Enterobacteriaceae, Aeromonadaceae, Pseudomonadaceae and 
Moraxellaceae. Abundances for all families in the phyla Proteobacteria were 
positively correlated with each other and with the abundance of Bacillaceae. 
Similar patterns were seen in full-thickness placental tissue samples at both 
the phylum and family level (Figure 12-8 & Figure 12-9). 
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Figure 12-7: Heat map of Spearman’s correlations between the 20 most 
abundant bacterial families in fetal membranes. 
Hierarchical clustering was computed by complete linkage of Euclidean distances. The heat 
map is annotated with mean difference in bacterial load between participants with and 
without severe chorioamnionitis for each bacterial family.  Asterisks indicate p<0·05 
association between higher load of that bacterial family and prevalence of severe 
chorioamnionitis. Adjusted model P values were calculated using linear regression adjusting 
for the nutritional intervention, maternal BMI at enrolment, maternal age, proxy for 
socioeconomic status, number of previous pregnancies, anaemia, site of enrolment, mode of 
delivery and time between delivery and placenta sampling. 
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Figure 12-8: Heat map of Spearman’s correlations between the 6 most 
abundant bacterial phyla in placental tissue. 
Hierarchical clustering was computed by complete linkage of Euclidean distances. The heat 
map is annotated with mean difference in bacterial load between participants with and 
without severe chorioamnionitis for each bacterial phylum.  Asterisks indicate p<0·05 
association between higher load of that bacterial phylum and prevalence of severe 
chorioamnionitis. Adjusted model P values were calculated using linear regression adjusting 
for the nutritional intervention, maternal BMI at enrolment, maternal age, proxy for 
socioeconomic status, number of previous pregnancies, anaemia, site of enrolment, mode of 
delivery and time between delivery and placenta sampling. 
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Figure 12-9: Heat map of Spearman’s correlations between the 20 most 
abundant bacterial families in placental tissue. 
Hierarchical clustering was computed by complete linkage of Euclidean distances. The heat 
map is annotated with mean difference in bacterial load between participants with and 
without severe chorioamnionitis for each bacterial family.  Asterisks indicate p<0·05 
association between higher load of that bacterial family and prevalence of severe 
chorioamnionitis. Adjusted model P values were calculated using linear regression adjusting 
for the nutritional intervention, maternal BMI at enrolment, maternal age, proxy for 
socioeconomic status, number of previous pregnancies, anaemia, site of enrolment, mode of 
delivery and time between delivery and placenta sampling. 
108 
 
 
 
12.3.6 Severe chorioamnionitis 
A total of 258 (26·1%) participants had histologically determined 
chorioamnionitis with 120 (12·1%) participants classified as having severe 
chorioamnionitis. Presence of chorioamnionitis was not significantly 
associated with birth outcomes, however, participants with severe 
chorioamnionitis delivered significantly earlier (-0·4 (-0.8,-0·1) gestational 
weeks, p=0·019) than those without severe chorioamnionitis. Those with 
severe chorioamnionitis also had a lower observed number of OTUs in the 
placenta (p=0·029) and fetal membranes (p=0·025) and increased intra-
individual unweighted UniFrac distances in the placenta (p=0·034) and fetal 
membranes (p=0·003) (Figure 12-10 & Figure 12-11). Severe 
chorioamnionitis was also associated with distinct phyla.  
A higher mean Fusobacteria load of 0·41 (0·17, 0·64) Log10 16S rDNA 
copies/µl (p=0·001) and higher mean Tenericutes load of 0·18 (0·05, 0·30) 
Log10 16S rDNA copies/µl (p=0·006) were found in fetal membranes with 
severe chorioamnionitis (Figure 12-6). This was also reflected at a family 
level with a significantly higher mean bacterial load of Mycoplasmataceae 
(p=0·010), Leptotrichiaceae (p=0·001), and Veillonaceae (p=0·001) in 
placental tissues with severe chorioamnionitis (Figure 12-7). Abundances of 
Mycoplasmataceae, Leptotrichiaceae, and Veillonaceae were also all 
positively intercorrelated. 
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Figure 12-10: Comparison between observed number of OTUs and 
median intra-individual unweighted UniFrac distances in placental 
tissue and presence of severe chorioamnionitis. 
Adjusted model P values were calculated using linear regression adjusting for the 
intervention, maternal BMI at enrolment, maternal age, proxy for socioeconomic status, 
number of previous pregnancies, anaemia, site of enrolment, mode of delivery and time 
between delivery and placenta sampling (*p<0.05, **p<0.01). 
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Figure 12-11: Comparison between observed number of OTUs and 
median intra-individual unweighted UniFrac distances in fetal 
membranes and presence of severe chorioamnionitis. 
Adjusted model P values were calculated using linear regression adjusting for the 
intervention, maternal BMI at enrolment, maternal age, proxy for socioeconomic status, 
number of previous pregnancies, anaemia, site of enrolment, mode of delivery and time 
between delivery and placenta sampling (*p<0.05, **p<0.01). 
 
 
12.3.7 Microbial composition recovered from fetal 
membranes differed when the individual delivered early or 
when the newborn had restricted growth 
31 OTUs from fetal membranes were identified whose abundances were 
positively correlated with or belonging to bacterial families that were 
significantly associated with severe chorioamnionitis (denoted with an 
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asterisk in figure Figure 12-7). Generally organisms fell into two groups, 
those that were associated with a shorter duration of pregnancy and those 
that were associated with a smaller newborn size (birth weight, length-for-age 
z-score and head circumference-for-age z-score).  Higher bacterial loads of 
Fusobacterium nucleatum, Ureaplasma sp. and Gemella asaccharolytica 
were associated with a shorter duration of pregnancy (Table 12-3). Higher 
loads of Gardnerella vaginalis, Sneathia sanguinegens, Prevotella copri, 
Prevotella amnii, Lachnospiraceae sp., Blautia sp. and 
Phascolarctobacterium succinatutens were all significantly associated with 
smaller newborn size (Table 12-4, Table 12-5 & Table 12-6). After controlling 
for the false discovery rate using the Benjamini-Hochberg procedure, only a 
higher mean bacterial load of an unidentified Lachnospiraceae sp. was 
significantly associated with a lower newborn head circumference-for-age z-
score (Table 12-6). 
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Table 12-3: OTUs isolated from fetal membranes significantly associated with differences in duration of delivery. 
   Unadjusted analysis Adjusted analysis 
O.T.U ID 
(Custom 
database and 
greengenes) 
Greengenes Taxonomy Genbank BLASTN result 
Correlation 
coefficient 
P value
1
 N 
Regression 
coefficient 
(95%CI) 
P 
value
2
 
q 
value 
270856 g__Ureaplasma; s__ Ureaplasma sp. -0.11 0.003 737 
-0.33 (-0.56, -
0.09) 
0.007 0.217 
5119 g__Fusobacterium; s__ Fusobacterium nucleatum -0.11 0.003 737 
-0.43 (-0.78, -
0.08) 
0.015 0.233 
558508579 g__Gemella; s__ Gemella asaccharolytica -0.09 0.018 737 
-0.12 (-0.01, -
0.23) 
0.027 0.279 
3677 f__Peptostreptococcaceae; g__ Clostridium sp. 0.08 0.024 737 
0.04 (-0.04, 
0.14)  
0.349 1.000 
1
 P value calculated using Pearson’s correlation. 
2
 Adjusted p-values were calculated using linear regression models. Regression coefficient shows the change in duration of delivery (weeks) in relation to an increase in 
bacterial load of 1 Log10 genomes/µl. All models were adjusted for the intervention, maternal BMI at enrolment, maternal age, proxy for socioeconomic status, number of 
previous pregnancies, anaemia, site of enrolment, mode of delivery and time between delivery and placenta sampling.
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Table 12-4:  OTUs isolated from fetal membranes significantly associated with differences in birth weight. 
   Unadjusted analysis Adjusted analysis 
O.T.U ID 
(Custom 
database and 
greengenes) 
Greengenes Taxonomy Genbank BLASTN result 
Correlation 
coefficient 
P 
value
1
 
N 
Regression 
coefficient 
(95%CI) 
P 
value
2
 
q 
value 
645321357 g__Sneathia; s__ Sneathia sanguinegens -0.10 0.008 681 -25 (-44, -7) 0.008 0.248 
288932 Prevotella; s__copri Prevotella copri -0.10 0.012 681 -51 (-94, -9) 0.018 0.279 
10703 f__Bifidobacteriaceae Gardnerella vaginalis -0.08 0.028 681 -19 (-37, 0) 0.045 0.465 
631251895 g__Prevotella; s__ Prevotella amnii -0.08 0.030 681 -24 (-56, 9) 0.158 1.000 
1
 P value calculated using Pearson’s correlation. 
2
 Adjusted p-values were calculated using linear regression models. Regression coefficient shows the change in birth weight (grams) in relation to an increase in bacterial load 
of 1 Log10 genomes/µl. All models were adjusted for the intervention, maternal BMI at enrolment, maternal age, proxy for socioeconomic status, number of previous 
pregnancies, anaemia, site of enrolment, mode of delivery and time between delivery and placenta sampling.
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Table 12-5: OTUs isolated from fetal membranes significantly associated with differences in length-for-age Z-score. 
   Unadjusted analysis Adjusted analysis 
O.T.U ID 
(Custom 
database and 
greengenes) 
Greengenes Taxonomy Genbank BLASTN result 
Correlation 
coefficient 
P 
value
1
 
N 
Regression 
coefficient 
(95%CI) 
P 
value
2
 
q value 
2386814 f__Lachnospiraceae; g__; s__ Lachnospiraceae sp. -0.11 0.006 644 -0.3 (-0.5, -0.1) 0.005 0.199 
10703 f__Bifidobacteriaceae Gardnerella vaginalis -0.08 0.044 644 -0.1 (-0.1, -0.0) 0.007 0.678 
645321357 g__Sneathia; s__ Sneathia sanguinegens -0.08 0.036 644 -0.1 (-0.1, -0.0 0.020 0.372 
302279 g__Phascolarctobacterium; s__ 
Phascolarctobacterium 
succinatutens 
-0.09 0.026 644 -0.1 (-0.3, -0.0) 0.024 0.203 
288932 g__Prevotella; s__copri Prevotella copri -0.09 0.017 644 -0.1 (-0.8, -0.1) 0.025 0.107 
2700884 f__Lachnospiraceae Blautia sp. -0.08 0.048 644 -0.4 (-0.7, -0.0) 0.032 0.248 
1
 P value calculated using Pearson’s correlation. 
2
 Adjusted p-values were calculated using linear regression models. Regression coefficient shows the change in length-for-age Z-score in relation to an increase in bacterial 
load of 1 Log10 genomes/µl. All models were adjusted for the intervention, maternal BMI at enrolment, maternal age, proxy for socioeconomic status, number of previous 
pregnancies, anaemia, site of enrolment, mode of delivery and time between delivery and placenta sampling.
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Table 12-6: OTUs isolated from fetal membranes significantly associated with differences in head circumference-for-age Z-
score. 
   Unadjusted analysis Adjusted analysis 
O.T.U ID 
(Custom 
database and 
greengenes) 
Greengenes Taxonomy Genbank BLASTN result 
Correlation 
coefficient 
P 
value
1
 
N 
Regression 
coefficient 
(95%CI) 
P 
value
2
 
q 
value 
2386814 f__Lachnospiraceae; g__; s__ Lachnospiraceae sp. -0.13 0.001 647 -0.4 (-0.6, -0.2) 0.000 0.003 
302279 g__Phascolarctobacterium; s__ 
Phascolarctobacterium 
succinatutens 
-0.11 0.007 647 -0.2 (-0.3, -0.1) 0.005 0.078 
645321357 g__Sneathia; s__ Sneathia sanguinegens -0.12 0.002 647 -0.1 (-0.1, -0.0 0.007 0.072 
288932 g__Prevotella; s__copri Prevotella copri -0.09 0.023 647 -0.1 (-0.2, 0.0) 0.067 0.519 
631251895 g__Prevotella; s__ Prevotella amnii -0.10 0.014 647 -0.1 (-0.2, 0.0) 0.125 0.775 
1
 P value calculated using Pearson’s correlation. 
2
 Adjusted p-values were calculated using linear regression models. Regression coefficient shows the change in head circumference-for-age Z-score in relation to an increase 
in bacterial load of 1 Log10 genomes/µl. All models were adjusted for the intervention, maternal BMI at enrolment, maternal age, proxy for socioeconomic status, number of 
previous pregnancies, anaemia, site of enrolment, mode of delivery and time between delivery and placenta sampling. 
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12.3.8 Source of Placental Bacteria 
SourceTracker (92) was used to identify the likely source for the bacteria 
detected in the placental and fetal membrane tissues. I identified 20 OTUs 
that were detectable from at least one participant’s placental tissue or fetal 
membrane and were also present in a matched individual sample from either 
the vagina or oral cavity. I compared their abundances with proportions of 
bacteria identified from SourceTracker as being from either the vagina or the 
oral cavity. 16 OTUs were positively associated with only a single source site 
using SouceTracker’s predictions, with 14 OTUs from the vagina and two 
from the oral cavity (Figure 12-12). Four bacteria could not be positively 
correlated with either source and so were not taken forward into subsequent 
analysis.   
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Figure 12-12: Identifying individual OTUs in placental and fetal 
membrane tissues sourced from either the vagina or oral cavity.  
The heat map plots the Spearman’s rho correlations between the proportion of OTUs in each 
individual that was predicted to be sourced from either the vagina or the oral cavity and 
individual OTU abundances. If both are positively correlated, it is assumed that the OTU is 
likely to have come from that source. Hierarchical clustering was computed by complete 
linkage of Euclidean distances. 
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A larger proportion of OTUs were identified as being sourced from the vagina 
than from the oral cavity (Figure 12-13). Also, similar proportions of 
organisms from the vagina were found in vaginally delivered and C-section 
delivered placenta and fetal membranes (Figure 12-14). A high proportion of 
organisms found within the placenta and fetal membranes did not have an 
obvious source (Figure 12-13).  
 
 
 
 
Figure 12-13: The mean ± SEM proportion of OTUs in placenta and fetal 
membranes predicted to be from either vaginal, oral cavity or an 
unknown source. 
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Figure 12-14: The mean ± SEM estimated proportion of OTUs in 
placenta and fetal membranes sourced from the vagina stratified by 
whether they were delivered vaginally or by C-section. 
 
 
Participants were clustered into groups by whether they had these 14 
vaginally sourced OTUs within either their placenta or fetal membrane 
tissues (Figure 12-15).  In one cluster, participants had evidence of multiple 
OTUs present in the vagina and in the placenta. In a second cluster 
participants had no evidence of these organisms within the vagina or 
placenta and a third cluster consisted of participants who had a combination 
of these 14 organisms in the vagina but not in the placenta.  
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Figure 12-15: Presence of vaginal organisms in the placenta across all participants. 
Hierarchical clustering was computed using complete linkage of Euclidean distances. Individuals were ranked by whether an OTU could be identified in both a 
matched vaginal and placental sample, only in the vaginal and sample or in neither the vagina nor the placenta.  
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Individuals were grouped by whether they had a detectable presence of 
these OTUs in their vagina and placenta and the mean LAZ score was taken 
for each group (Figure 12-16). The mean LAZ score was lowest in individuals 
when the organisms were present in both the vagina and placenta, with the 
highest mean LAZ score when the organisms were not present at all. This 
trend was statistically significant when Sneathia sanguinengens and 
Peptostreptococcus anaerobius were detected in the vagina and placental 
tissues (q<0.05). There were no significant associations between the 
presence of any of the same organisms and duration of pregnancy, birth 
weight or neonatal head circumference.  
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Figure 12-16: LAZ score for individuals grouped by presence of vaginal 
OTUs. 
Mean LAZ scores were plotted with error bars representing 95% confidence intervals. 
Individuals were group by whether an OTU could be identified in both a matched vaginal and 
placental sample, only in the vaginal and sample or in neither the vagina nor the placenta. 
Mean values across the three groups were compared using one-way ANOVA (*q<0.05). 
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12.4 Discussion 
This is the largest study to date of placental microbiota with over 1000 
individuals with tissue available. Bacteria were found in more than 50% of 
placental tissues and the core microbiome was distinct from the oral and 
vaginal microbiome. This microbial community structure was altered in 
individuals with severe chorioamnionitis. The abundance of these altered 
bacteria were associated with birth outcomes and the predominant source for 
these bacteria was from the vagina.  
A study by Aagaard et al (80) of 320 placental samples was recently 
published and showed that the taxa in the placenta resembled the oral 
microbiome more than the vagina, gut or skin. They found that certain genera 
had increased abundance in those who delivered preterm compared to term, 
including Burkholderia, Anaeromyxobacter, Streptosporangium and 
Roseovarius. These genera have not been previously associated with 
preterm birth and include environmental organisms or those associated with 
reagent contamination of sequencing studies (84).  Samples with low 
bacterial biomass, such as from the placenta, are susceptible to reagent, 
delivery and environmental contamination. Using positive and negative 
sequencing controls and controlling for the effects of mode of delivery, I have 
tried to mitigate these effects. The majority of full-thickness placental tissue 
sections had no detectable bacterial DNA and comparable numbers of 
bacteria from the vagina in both caesarean sections and vaginally delivered 
samples. This suggests that contamination of samples during delivery and 
processing occurred at a relatively low level. The majority of individuals had 
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an OTU rich placental microbiome, containing OTUs that could not be found 
in either matched or unmatched vagina or oral cavity samples. A minority of 
individuals had a relatively small number of phylogenetically diverse OTUs 
that could also be found in matched vaginal samples and it seems likely that 
these features represent ‘true’ infection of the placental tissue.  
Many of the OTUs I identified as being inversely correlated with duration of 
delivery have previously been associated with preterm birth. Fusobacterium 
nucleatum and Ureaplasma spp. have frequently been found in the amniotic 
fluid of women who deliver preterm (155,156,58). Although not commonly 
reported, recent molecular studies have found Sneathia sanguinegens, 
Prevotella spp., Peptostreptococcus spp. and Gardnerella vaginalis in both 
amniotic fluid and placental tissues of women who have delivered 
prematurely (57,63). Interestingly, several OTUs associated with a shorter 
duration of pregnancy and smaller newborn size in our study have been 
previously associated with bacterial vaginosis such as Gardnerella spp., 
Ureaplasma spp., Sneathia spp., Prevotella spp. and Lachnospiraceae spp. 
(157,158). This includes a recent study that found a higher abundance of 
Gardnerella and Ureaplasma in the vaginas of women during pregnancy who 
subsequently delivered preterm (159). I found that the presence of 
Peptostreptococcus anaerobious and Sneathia sanguinegens in both the 
vagina and placenta was associated with smaller newborn size, which 
provides further evidence supporting the view that ascending infection, and 
hence the vaginal microbiome, may play an important role in birth outcomes. 
However it is not possible to exclude a role for the oral microbiome in 
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seeding placental tissue, as has been previously suggested (78), as I have 
found the same OTUs in the oral cavity and placenta for some individuals. 
Also, the oral sample collected in this study was a swab of the gingival 
margins and may not isolate the bacteria found in deep periodontal pockets 
or periapical tissues that I now know have an association with adverse birth 
outcomes in this cohort (160). 
Severe chorioamnionitis was associated with a shorter duration of 
pregnancy. Moreover, certain bacterial phyla were associated with 
chorioamnionitis and also with each other. Based on these distinct microbial 
profiles, participants enrolled in this study fell broadly into two groups: one 
group dominated by species in the Proteobacteria or Firmicutes phyla and a 
second group dominated by a set of phylogenetically different organisms, 
mainly from the Fusobacteria and Tenericutes phyla. It was the second group 
who were more likely to have widespread inflammation in their placental 
tissue, deliver early and deliver a smaller newborn. In particular, higher loads 
in the load of these two phyla that appeared to be associated with severe 
chorioamnionitis. 
While there are no comparable data from Africa, studies across Europe and 
North America have shown some similarity between the organisms I have 
identified and those identified in amniotic fluid (60,161) or placental tissues 
(64,162). In a different trial in Malawi, prospectively treating women with 
antibiotics during pregnancy had a protective effect on the incidence of 
preterm birth and low birth weight (163). This could be explained by the 
possible clearing of potential pathogens responsible for ascending infection 
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that could then be leading to preterm birth or growth restriction. The gut 
microbiome is known to differ significantly between western and African 
populations (164) and I found a minority of OTUs such as a Blautia sp., 
Phascolarctobacterium succinatutens and a Lachnospiraceae sp. that have 
not previously been associated with adverse birth outcomes. It is unknown at 
the moment whether these are faecal contaminants or regional differences 
between this study and previous studies.  
In summary, I have identified a distinct microbial community in the placenta 
and fetal membranes that are associated with severe chorioamnionitis and 
poor birth outcomes in a large cohort in rural Malawi. Bacteria associated 
with both severe chorioamnionitis and poor birth outcomes were 
phylogenetically diverse and not the most abundant taxa recovered in the 
placenta or fetal membranes. Interestingly, none of the species associated 
with preterm birth were significantly associated with any of the three 
measures of growth restriction. Further studies are needed to elucidate 
mechanisms by which bacteria restrict fetal growth without triggering 
chorioamnionitis or preterm labour. Previous studies on the use of antibiotics 
in treating infection as a cause of preterm delivery have had limited success 
(165,166). A therapeutic approach targeted against the types of bacteria 
associated with poor birth outcomes may prove more successful, this is 
supported by trials using clindamycin that have reduced the risk of preterm 
birth and late miscarriage (167). Strategic control of the microbiome resident 
in the vagina or oral cavity, using antibiotics or probiotics with proven efficacy 
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against organisms identified in this study could potentially control potential 
etiologic agents that spread to the placenta. 
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13 Chapter 6: The vaginal microbiome in rural Malawi. 
 
13.1 Introduction 
Abnormal vaginal microbiota is an alteration in the microbial community that 
is otherwise predominated by lactobacilli species. Previous studies have 
found individuals lacking an abundance of lactobacilli are more likely to 
develop other conditions such as bacterial vaginosis (BV) or aerobic vaginitis 
(AV) and have an increased risk in transmission of sexually transmitted 
infections (168). BV is defined by an overabundance of anaerobic organisms 
such as Gardnerella vaginalis, Prevotella spp. and Bacteroides spp. (169) 
and has previously been identified by a change in vaginal pH, vaginal 
discharge and a fishy odour. However symptoms can be rare and many 
women that have BV are asymptomatic. Another vaginal microbiota disorder 
is aerobic vaginitis, defined by the overabundance of aerobic bacteria such 
as Escherichia coli Staphylococcus spp. and group B Streptococci (170). It 
differs from BV not only in the aerobic environment in creates in the vaginal 
microbiota but also correlates with increased levels of toxic leukocytes and 
parabasal cells in the epithelium. This strong inflammatory response can lead 
to itching and burning sensations but has also been linked to preterm birth 
and miscarriage (171). 
Incidence of abnormal vaginal microbiota during pregnancy has been 
associated with adverse birth outcomes, in particular preterm birth 
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(66,171,172,65,173) which is the largest cause of neonatal deaths worldwide. 
Incidence of preterm birth is highest in low-income countries like Malawi 
(152). Amongst a variety of risk factors, infection has been estimated as the 
probable cause of preterm birth in 25-40% of cases and ascending infection 
has long been associated as the potential source of organisms invading 
maternal and fetal tissues (4). Many of the organisms historically involved in 
intrauterine infections are commonly found in the genital tract (174) 
While previous work in diagnosing BV has used scoring of Gram stains (175), 
recent studies have been using molecular techniques focusing on the 
amplification of the 16S rRNA gene to elucidate how structure shifts between 
Lactobacilli dominated and BV communities (87,176). These studies 
exclusively acquire data from high-income countries, especially the USA. 
Ethnicity seems to influence the vaginal microbiome (158) but there have 
been no studies focusing on low-income populations in Africa. Prevalence of 
BV in Malawi has been studied and found to be as high as 85.5%,diagnosed 
using Amsel criteria (vaginal fluid pH >4.5, clue cells on microscopy, 
nonspecific vaginitis discharge and positive potassium hydroxide odour) 
(177). No attempt has been made to characterise the bacteria involved. 
The aim of this study was to characterise the vaginal microbiome of a large 
cohort of pregnant women in rural Malawi using 16S rDNA amplicon 
sequencing. I wanted to expand the current knowledge base for the structure 
of the vaginal microbiome in a low-income, African setting and investigate 
possible associations between the abundance of certain organisms and birth 
outcomes.  
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13.2 Materials and Methods 
  
13.2.1 Study design and enrolment 
See section 9.1. 
 
13.2.2 Study setting 
See section 9.2. 
 
13.2.3 Collection of birth outcome and baseline data 
See section 9.3. 
 
13.2.4 Sample collection 
See section 9.4. 
 
13.2.5 DNA Extraction 
See section 9.5. 
 
13.2.6 16S rDNA amplicon high-throughput sequencing 
See section 9.7. 
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13.2.7 Bioinformatics and statistical analysis 
See section 9.8. 
 
13.2.8 Ethical approval and consent 
See section 9.9. 
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13.3 Results 
 
13.3.1 Sample collection 
Starting in February 2011 a total of 1391 pregnant women were recruited into 
the iLiNS-DYAD-M trial, with the last delivery taking place in February 2013. 
A vaginal microbiome was characterised in 1107 (79.6%) participants. Figure 
13-1 shows that of those excluded, 222 were lost to follow up, 11 were 
excluded due to twin deliveries and 51 failed sequencing.  
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Figure 13-1: Study participant flow diagram. 
 
 
When the participants that were included in this study were compared to 
those excluded they tended to be older (25y vs 24y, p=0.025), had 
completed less time in education (3.9y vs 4.5y, p=0.049), had a lower proxy 
for socioeconomic status (-0.05 vs 0.30, p<0.001) and were more likely to be 
primiparous (29.6% vs 20.0%, p=0.001) (Table 13-1). Sequencing 1107 
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samples from individual participants and filtering for quality and error allowed 
analysis at a median depth of 14,585 reads per sample (IQR: 7,986 to 
21,659) from 18,661,136 reads in total. 
 
Table 13-1: Baseline characteristics of included and excluded 
participants 
Characteristic 
Included 
(n=1107)
1
 
Excluded 
(n=272)
1
 
P value
2
 
Mean (SD) BMI, kg/m
2
 22.1 (2.8) 22.4 (2.9) 0.126 
Mean (SD) maternal age, years 25.1 (6.10 24.2 (6.6) 0.025 
Mean (SD) maternal education, completed years at 
school 
3.9 (3.4) 4.5 (3.7) 0.049 
Mean (SD) proxy for socioeconomic status -0.05 (0.9) 0.30 (1.1) <0.001 
Proportion of aenemic women (Hb < 110 g/l) 29.6 % 20.1 % 0.001 
Proportion of primiparous women 4.1 % 5.7 % 0.367 
Proportion of women with a low BMI (< 18.5 kg/m
2
) 12.2 % 13.9 % 0.591 
Proportion of women with a positive HIV test 22.4 % 23.5 % 0.749 
Number (%) of women with a positive malaria test 
(RDT) 
23.4 % 22.7 % 0.874 
1
Total n=1391 
2 
P value obtained from t-test (comparison of means) or Fishers exact test (comparison of proportions)  
 
 
13.3.2 The vaginal microbiome of rural Malawian women is 
dominated by Gardnerella vaginalis with limited numbers of 
Lactobacillus spp. 
Figure 2 shows that Gardnerella vaginalis was the most common organism 
recovered from participant’s vaginal swabs. It was prevalent in 75.7% 
(838/1107) of participant’s genital tracts and was the only OTU found in 
>50% of individuals. In contrast, Lactobacillus spp. were found in the vaginal 
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microbiomes of just 30.4% (337/1107) participants. When Lactobacillus spp. 
were present they were usually Lactobacillus iners. A participant positive for 
the presence of Lactobacillus iners was also frequently positive for 
Gardnerella vaginalis. The relative abundances of these two organisms were 
significantly positively correlated (Spearman’s rho = 0.24, p<0.001).  
 
 
 
Figure 13-2: Rank abundance curve. 
The 25 most prevalent OTUs recovered from participants’ vagina (n=1107). 
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To identify the taxonomic groups that define the vaginal microbiota of this 
Malawian cohort I compared Spearman’s correlations between the 50 most 
abundant OTUs that accounted for 89.7% of all reads in the dataset. Figure 
13-3 shows that these OTUs separated into four taxonomic groups. The first 
group contained G. vaginalis, Leptotrichia amnionii, Sneathia sanguinegens 
Gemella asaccharolytica, Atopobium vaginae, Parvimonas sp. and a 
Clostridiales sp. Taxon group one was more likely to be negatively 
associated with the other three groups, especially taxonomic group two which 
consisted of F. magna, S. anginosus, Peptostreptococcus stomatis, 
Veillonella montpellierensis, Prevotella spp., Anaerococcus spp. and 
Corynebacterium spp.. P. anaerobious did not have a strong positive 
association with any of the other four taxonomic groups. 
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Figure 13-3: Heat map of pairwise Spearman’s correlations between the 50 most abundant OTUs. 
Hierarchical clustering by complete linkage of Euclidean distances was used to split the OTUs into four taxonomic groups. The heat map is annotated with Spearman’s 
correlation between the abundance of the OTU in that row and either vaginal pH, duration of pregnancy, birth weight, LAZ and HCZ.   
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To capture the diversity of the vaginal microbiome in each individual and to 
see if these taxonomic groups also defined groups of individuals, normalised 
read counts for the top 25 most abundant OTUs were compared and 
participants were clustered based on their microbiome composition (Figure 
13-4). Participants separated into two broad groups which are represented by 
the separately coloured clades in Figure 13-4. One group was defined by 
higher abundances of those organisms found in taxon group one and 
bacterial vaginosis-associated bacterium (BVAB)-3. The second group was 
more complex, containing a number of different sub-groups defined by higher 
abundance of Lactobacillus iners or clusters of OTUs containing 
Corynebacterium spp., Ureaplasma urealyticum, Mycoplasma hominis, 
Streptococcus anginosus, Peptoniphilus sp., Finegoldia magna and 
Anaerococcus spp. Both Gardnerella vaginalis and Peptostreptococcus 
anaerobious were present in abundance across a range of individuals and 
could not be associated with a single participant cluster. 
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Figure 13-4: Heat map of noramlised read counts from 25 most abundant OTUs in all participants. 
Read counts were noramlised using variance stabilizing transformation in DESeq2. Participants are clustered on their microbiota composition using hierarchical clustering by 
complete linkage of Euclidean distances. OTUs are group by their taxonomic group identified in Figure 13-3. The heat map is annotated by whether that participant was HIV-
positive or HIV-negative with the annotation left white if no information was available.
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Taxon group one was more likely to dominate the entirety of an individual’s 
vaginal microbiome, unlike the other taxon groups and P. anaerobius that 
often co-existed within the same individual (Figure 13-5). The core 
microbiome of 46.4% (514/1107) individuals was dominated by taxon group 
one (>50% relative abundance of taxon group one). In comparison only 
16.4% of individuals were dominated by taxon group four, 7.1% by taxon 
group two and 2.9% by taxon group three. 
 
 
Figure 13-5: Distribution of relative abundances of each taxon group 
amongst all participants. 
Taxon groups are the same as identified in Figure 13-4. Boxes define the taxon group’s 
median relative abundance along with the 25th and 75th percentiles. Error bars plot the 10th 
and 90th percentiles in the data with all outliers beyond this plotted as individual points. 
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13.3.3 Factors that may influence or could be influenced by 
vaginal microbial composition. 
13.9 % (154/1107) of individuals in this study were HIV positive. The heat 
map in Figure 13-4 was annotated with an individual’s HIV status to compare 
its possible association with microbial composition. HIV infection did not 
explain the observed structure of vaginal OTUs amongst participants. 
However, I compared differential abundances between OTUs in HIV-negative 
and HIV-positive participants using log-binomial regression. The two greatest 
differences in OTU abundance were in M. hominis and BVAB3 with a Log2-
fold increase in abundance of 0.77 and 0.58 in HIV-positive compared to 
HIV-negative participants, respectively. Both were not statistically significant 
changes after adjusting for FDR (q=0.05). 
Abundances of each OTU were compared using Spearman’s correlation with 
vaginal pH, gestational age at delivery, birth weight, newborn length-for-age 
z-score (LAZ) and head circumference-for-age z-score (HCZ) (Figure 13-3). 
Distinct patterns were seen between groups one and two with pH and birth 
outcomes. Increased abundances of taxonomic group one and P. 
anaerobious correlated with lower birth weight, lower newborn LAZ and lower 
HCZ. Higher abundances of taxonomic group 2 OTUs correlated with a lower 
pH and lower gestational age at birth. Taxonomic groups three and four, as a 
whole, had no distinct negative association with birth outcomes. 
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13.3.4 Associations between individual OTUs and adverse 
birth outcomes 
Using the taxonomic groups identified in Figure 13-3, I compared the 
association of individual OTUs within each group to four birth outcomes. 
There was a general trend across all individual OTUs from taxonomic group 
1 and P. anaerobius that an increased abundance corresponded with a lower 
birthweight, newborn LAZ and newborn HCZ. Increased abundances of P. 
anaerobius and P. amnii were both significantly associated with a lower 
newborn length for age z-score (q=0.023 and q=0.036, respectively) (Table 
2). When the association of individual OTUs found in taxonomic group 2 were 
compared to vaginal pH and duration of pregnancy, although the same 
trends were seen as for group 2 as a whole, there were no statistically 
significant associations for individual OTUs seen after adjusting for false 
discovery rate (supplementary table 1). 
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Table 13-2: Association between birth weight, newborn LAZ, HCZ and OTUs belonging to taxonomic group one including 
P. anaerobius. 
 Outcome 
 
Birth weight, grams 
(n=1008) 
 
Newborn length-for-
age Z score (n=979) 
 
Newborn head 
circumference-for-age Z 
score (n=982) 
 
OTU 
Adjusted regression 
coefficient
2
 (95% CI) 
q value
1
 
Adjusted regression 
coefficient
2
 (95% CI) 
q value
1
 
Adjusted regression 
coefficient
2
 (95% CI) 
q value
1
 
Peptostreptococcus anaerobius -7 (-14, 0) 0.306 -0.03 (-0.04, -0.01) 0.023 -0.02 (-0.04, -0.01) 0.023 
Parvimonas sp. -9 (-18, 1) 0.279 -0.02 (-0.04, 0.01) 0.389 -0.02 (-0.04, 0.01) 0.389 
Atopobium vaginae -0 (-8, 7) 0.922 -0.00 (-0.02, 0.02) 1.000 -0.01 (-0.03, 0.01) 1.000 
Gemella assacharolytica 3 (-5, 10) 0.722 -0.01 (-0.02, 0.01) 0.831 -0.00 (-0.02, 0.02) 0.831 
Sneathia sanguinegens -6 (-13, 1) 0.250 -0.02 (-0.04, -0.00) 0.057 -0.01 (-0.03, 0.01) 0.057 
Gardnerella vaginalis -2 (-8, 4) 0.735 -0.00 (-0.02, 0.02) 0.989 -0.01 (-0.03, 0.01) 0.989 
Leptotrichia amnionii -1 (-8, 6) 0.849 0.00 (-0.01, 0.02) 0.872 -0.01 (-0.02, 0.01) 0.872 
Prevotella amnii -10 (-19, -1) 0.297 -0.03 (-0.05, -0.01) 0.036 -0.02 (-0.04, 0.01) 0.036 
Clostridiales sp. -4 (-12, 5) 0.679 -0.01 (-0.03, 0.01) 0.526 -0.01 (-0.03, 0.02) 0.526 
1
P values calculated by linear regression and q values were generated by controlling for the false discovery rate using the Benjamini-Hochberg method. Regression models 
show the change in birth outcome measured with an increase in OTU’s noramlised read count of one. All models  were adjusted for nutritional intervention, maternal BMI at 
enrolment, maternal age, proxy for socioeconomic status, number of previous pregnancies, maternal anaemia at enrolment and site of enrolment. 
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Table 13-3: Association between vagina pH, duration of pregnancy and OTUs belonging to taxonomic group two. 
 Outcome 
 Vaginal pH (n=942)  Duration of pregnancy, weeks (n=1107)  
OTU Adjusted regression coefficient
2
 (95% CI) q value
1
 Adjusted regression coefficient
2
 (95% CI) q value
1
 
Peptinophilus sp. -0.00 (-0.03, 0.02) 0.881 -0.02 (-0.08, 0.03) 1.000 
Finegoldia magna -0.01 (-0.04, 0.02) 1.000 -0.02 (-0.08, 0.04) 0.803 
Corynebacterium amycolatum -0.00 (-0.03, 0.03) 0.957 -0.02 (-0.08, 0.04) 0.714 
Anaerococcus lactolyticus -0.02  (-0.05, 0.01) 0.449 0.03 (-0.04, 0.09) 1.000 
Corynebacterium sp. -0.02 (-0.05, -0.01) 0.506 -0.02 (-0.08, 0.04) 0.823 
Streptococcus anginosus -0.02 (-0.05, 0.01) 0.385 0.03 (-0.03, 0.09) 1.000 
Prevotella timonensis  -0.03 (-0.05, 0.00) 0.297 0.00 (-0.05, 0.05) 0.956 
Anaerococcus tetradius -0.00 (0.03, 0.02) 0.877 0.02 (-0.03, 0.08) 0.939 
Prevotella bivia -0.02 (-0.04, -0.00) 0.517 0.02 (-0.02, 0.06) 1.000 
Veillonella montpellierensis -0.01 (-0.03, 0.01) 0.587 -0.01 (-0.05, 0.04) 0.854 
Peptostreptococcus stomatis -0.01 (-0.04, 0.01) 0.783 -0.01 (-0.07, 0.05) 0.937 
1
P values calculated by linear regression and q values were generated by controlling for the false discovery rate using the Benjamini-Hochberg method. Regression models 
show the change in birth outcome measured with an increase in OTU’s noramlised read count of one. All models were adjusted for nutritional intervention, maternal BMI at 
enrolment, maternal age, proxy for socioeconomic status, number of previous pregnancies, maternal anaemia at enrolment and site of enrolment. 
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13.4 Discussion 
In this study I have characterised the vaginal microbiome of 1,107 women in 
Southern Africa. This represents the largest cross-sectional study of its kind 
to date and one of the few studies in an African population (149,178,179). I 
have shown that a diverse microbial community deficient in Lactobacillus 
spp. dominates the vaginal samples in this cohort of women. A proportion of 
individuals who have delivered babies with lower LAZ and HCZ tend to have 
a particular combination of bacterial vaginosis associated bacteria which 
included higher abundances of P. anaerobius and P. amnii. 
Studies that have analysed the vaginal microbiome using 16S rDNA 
amplicon sequencing have concluded that the majority of the population has 
a microbiome dominated by Lactobacillus spp. and a less prevalent group of 
BV-associated organisms (87,180,159). These have taken place in 
predominantly white Caucasian populations from U.S.A or Europe. Ethnic 
differences between populations in the U.S.A have been studied and there 
are show some similarities with our findings. Those with African American 
ancestry have been found to have a higher prevalence of Prevotella spp., 
Dialister spp., Atopobium spp., Gardnerella spp., Peptoniphilus spp., 
Sneathia sanguinegens. Aerococcus spp, Finegoldia magna and a 
decreased prevalence of Lactobacillus spp. when compared to other groups 
(87). A study explicitly comparing participants with African American and 
European ancestry found that those with African American ancestry had a 
“healthy” microbiome dominated by M. hominis, Aerococcus spp, 
Anaerococcus spp, Dialister spp, Peptoniphilus spp., Parvimonas spp,, S. 
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sanguinegens , P. amnii, Atopobium spp. and G. vaginalis. When 
Lactobacillus spp. were found in an African American cohort, as noted in this 
study, it was most likely to be L. iners (158). Two studies in East Africa that 
have used marker gene studies to characterise the vaginal microbiome have 
focused on either HIV-positive women and those with BV and so the results 
cannot be extrapolated to see how the population looks as a whole 
(178,179). As well as ethnic differences, regional microbiome differences 
have previously been established in gut studies (164), however comparable 
data for the vagina has not been available until now. Other environmental 
factors such as vaginal douching are common to this region (181). However 
there is some disagreement on whether this can (182,183), or cannot (179), 
alter the vaginal microbiota.  
This cross-sectional study sampled the vaginal microbiome at one week 
post-partum. During pregnancy, longitudinal studies have found that specific 
community structures are more stable than others (184) and that as 
pregnancy progressed there was an increase in abundance of Lactobacillus 
spp. (180). However, studies looking at the post-partum vaginal microbiome 
showed an abrupt drop in abundance of Lactobacillus spp and an increase in 
Prevotella spp., Anaerococcus spp., Streptococcus spp and Peptoniphilus 
spp (159,185). It is known that oestrogen levels post-partum change 
substantially and fall up to a 1000-fold in some cases, having a significant 
effect on bacterial community members. A recent study sampled the vaginal 
microbiome in an African population in Tanzania before and after delivery 
and found that while during pregnancy the microbiome was generally still 
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dominated by Lactobacillus spp. there was a large shift post-partum 
(between 3 days and 1 month after birth) (149). Although the numbers of 
individuals studied were low compared to this study, it showed many 
similarities with higher abundances of Prevotella spp., Gardnerella spp. and 
Sneathia spp. However, there was still a relative high prevalence of 
Lactobacillus spp. post-partum in the Tanzanian cohort compared to this 
Malawian cohort. This could be explained by the lower incidences of adverse 
birth outcomes such as preterm birth (5%) compared to the population in this 
study (10%). An extensive longitudinal study is needed to confirm both the 
stability of these community structures over time and shifts in microbial 
composition pre- and post-partum.  
Although BV has previously been associated with preterm birth, I found the 
majority of participants in this study were dominated with BV-associated 
bacteria, and similar to another large study (180), they could not all explain 
incidences of adverse birth outcome. I found that BVAB-3, previously 
associated with BV patients, was positively associated with a longer duration 
of delivery. Interestingly, in an African American population, an increased 
bacterial load of BVAB3 identified by qPCR was also associated with a 
decreased risk of preterm birth (186). BV is more prevalent in Malawi than in 
the U.S.A and Europe, with incidences between 35% and 85.5% previously 
diagnosed using a mixture of Amsel and Nugent (based on the observation of 
specific morphotypes under the microscope after Gram stain) methods 
(177,181,187). Taxonomic groups one and two contain anaerobic bacteria 
that could represent an altered BV microbiota in this population. I found that 
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Prevotella amnii and Peptostreptococcus anaerobius were both found to be 
significantly associated with a measure of intrauterine growth restriction. 
Interestingly, it has been shown that Prevotella spp. provide amino acids that 
increase the growth of P. anaerobius in vitro and it seems likely that  similar 
symbiotic relationships exist between the species within the groupings 
identified in this study (188).  
Taxonomic group three could represent a mixed community of both BV and 
AV flora, with previously identified AV flora such as Staphylococcus aureus 
and Streptococcus agalactiae present in high abundance alongside BV-
associated genera such as Prevotella spp, Parvimonas spp and 
Coriobacteriales spp. (170). Although AV has been previously associated 
with preterm birth (171), I found no associations with birth outcomes 
measured in this study and the prevalence of these organisms across the 
entire population was very low.  
Administration of antibiotics in pregnancy in Africa have been shown to 
reduce the risk of preterm birth and low birth weight (163,189,190), 
presumably by eradicating certain vaginal bacteria and reducing the risk of 
ascending intrauterine infection. Microbial therapy or administration of 
probiotics could promote the growth of commensal microbiota but a better 
understanding of how the vaginal microbial community differs in these 
populations is needed first to inform any future interventions. 
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14 Chapter 7: Conclusion 
In this thesis I have demonstrated a successful method for identifying the 
microbial community structure of the placenta and vagina from a rural, low-
income setting. Through using this method I have shown distinct community 
structures in the placenta and vagina are associated with chorioamnionitis 
and adverse birth outcomes. When interpreting the placental high-throughput 
sequencing results, one the biggest challenges was differentiating genuine 
signal from contamination. There were a number of different sources of 
contamination in this dataset and it was a challenging setting to carry out 
sensitive bacterial DNA detection. Potential sources of contamination 
included during deliveries in hospital and health centres that might not have 
sterile equipment and the threat of constant electricity black-outs during the 
storage of samples at local sites. It might not be feasible to avoid all possible 
contamination but if the correct positive and negative controls were used I 
have shown it is possible to filter potential noise from the dataset post-
sequencing. While a study in the UK could be designed to avoid these 
possible pitfalls, this might be the only workaround in a rural sub-Saharan 
African setting. 
It is still undecided whether the placenta is truly a sterile site or not. Results 
from sequencing low biomass samples such as these can be heavily effected 
by contamination after the sample is collected and after the genomic DNA is 
extracted. High-throughput sequencers are now able to process thousands of 
samples to a depth spanning millions of reads which gives it unprecedented 
sensitivity if viable DNA is loaded onto the machine. Previous studies using 
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molecular techniques to detect bacteria in the placenta have used less 
sensitive techniques (63). However a recent high-throughput sequencing 
study has suggested that all placentas have a resident microbiome (80). As 
mentioned previously, many of the bacteria recovered were environmental 
organisms, known to be present in a lot of the laboratory reagents used in the 
preparation and amplification of DNA (84). In this project, I screened samples 
using a broad-range 16S rDNA qPCR to define samples that would go 
forward for high-throughput sequencing. Using a less sensitive technique 
before going ahead with high-throughput sequence would reduce future 
issues with reagent contamination. This was corroborated by the fact that 
positive samples with the lowest bacterial loads were both more likely to have 
a higher relative abundance of environmental organisms that were found in 
the negative sequencing controls and were more likely to contain higher 
abundances of the Sphingomonas sp. identified in Figure 10-7. The same 
problem was not encountered when I sequenced samples from established 
microbial communities such as the vagina and the oral cavity. A screening 
method such as the broad-range 16S rDNA qPCR might be necessary for 
low biomass samples such as placental tissue to provide reliable datasets in 
the future and previous studies not taking this into account need to have their 
results reassessed in light of this. 
Further improvements are needed in reducing PCR error, sequencing error 
and the reliable assignment of OTUs. At the family level there was a strong 
association between certain taxa and adverse birth outcomes in this study 
that was largely lost when comparing individual OTUs. Current OTU picking 
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strategies that define sequence bins based on global sequence similarity can 
mistakenly split what should be a single OTU into many spurious OTUs as 
previously shown in Figure 10-9. Some progress is being made with a move 
away from global thresholds to a more iterative, de novo approach (191). 
Another largely understudied problem in this field is also the use of large, 
curated 16S rDNA databases in the assignment of both OTUs and taxonomy 
to samples. Although proper comparison studies are needed to elucidate the 
exact effects, it seems that there is a trade off in attempting to represent all 
bacterial environments and the ability to successfully separate sequences 
that could originate from biologically different organisms. Computational 
requirements are drastically reduced when using a restricted database and 
although there is time saved on using pre-curated databases, a two-step 
OTU picking approach can be used with a database tailored to the study 
question. This might be more suited to current OTU and taxonomy 
assignment algorithms. 
Although not included in the scope of this thesis, further work will be needed 
to elucidate any minor alterations the nutrient interventions might be having 
on various organism found in the placenta, vagina and oral cavity. All 
comparisons between bacteria and birth outcomes in this thesis were 
controlled for the effect of the intervention using relevant regression models. 
However comparisons between phylogenetic diversity in the various 
microbiomes between different intervention arms would only reveal very 
broad shifts in community structure. If lipid-based nutrient supplements are 
going to be sold locally in Malawi to reduce the prevalence of chronic 
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undernutrition, then further work is needed to characterise its impact on the 
microbiome and especially oral health. 
Collaborators on this project have published that periapical infections in the 
same cohort were associated with both shorter duration of pregnancy and 
IUGR (160). This would provide further evidence for a case of 
haematogenous spread of bacteria from the mouth to the placenta and 
perhaps infection of the foetus itself. We only reliably detected two oral 
organisms that could be traced in both matched oral and placental samples. 
This included Group B Streptococci which has previously been implicated in 
preterm birth (192,193) but was not associated with adverse birth outcomes 
in this population. It is known that many of the more problematic oral 
pathogens, like Fusobacterium nucleatum, are anaerobes found in increasing 
numbers at greater pocket depth (194). F. nucleatum was detected at 
relatively high prevalence in placental tissue in this study and at the family 
level. Greater abundances of Fusobacteriaceae were also associated with 
both a higher prevalence of severe chorioamnionitis and a lower duration of 
delivery. This pathogen has long been associated with adverse birth 
outcomes (61); however the prevalence in the oral samples was very low. 
Many participants had a placental tissue sample dominated by F. nucleatum 
that was completely absent from a matched participant oral swab. One 
explanation would be that the F. nucleatum we sampled was being 
introduced from a different source. However, I think a more likely reason for 
this discrepancy is the type of sample taken in this study. It is more likely the 
full diversity of oral bacteria in these participants was not identified. Any 
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future studies need to sample at multiple sites, including deep periodontal 
pockets, in order to discover reliable associations between oral pathogens 
and adverse birth outcomes. 
Based on the results of this thesis, a therapeutic intervention (either 
antibiotics or probiotics) in this population that had proven efficacy against P. 
anaerobious, P. amnii and S. sanguinegens early in pregnancy might be an 
ideal next step to reduce the prevalence of newborn stunting and low birth 
weight. The ability to screen for these organisms using species-specific PCR 
might also be useful in targeting at-risk populations. However, I think further 
studies are needed to confirm these associations. Longitudinal sampling of 
the vagina is needed at regular intervals throughout pregnancy and after 
delivery. Unfortunately the only available vaginal microbiome time point in 
this study was one week post-partum, and as previously mentioned, a wide 
variety of changes make it difficult to draw conclusions as to microbial 
community structure pre-partum. The stark contrasts however between the 
results between different ethnic groups in both prevalence of preterm birth, 
BV and even healthy vaginal tract microbiota suggest that a greater variation 
in community structure than perhaps previously thought. Despite this, these 
results provide further evidence of the important role the vaginal microbiome 
may play in seeding organisms found on placental tissues in rural Malawi and 
therapeutic interventions could be designed to impact the microbiome with 
the goal of reducing the risk of preterm birth or intrauterine growth restriction. 
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16 Appendix 
 
16.1 Qiime script settings 
 
#Pick OTUs 
parallel_pick_otus_uclust_ref.py -i /data/seqs.cat.fna -o /data/pick_otus/ -r 
/data/97_named_trimmed_reference.fasta -O 159 –T 
filter_fasta.py -f /data/seqs.cat.fna -o /data/pick_otus/seqs.cat_failures.fasta -s 
seqs.cat_failures.txt 
parallel_pick_otus_uclust_ref.py -i /data/pick_otus/seqs.cat_failures.fasta -o 
/data/pick_otus/failures/ -r /home/ubuntu/qiime_software/gg_otus-12_10-
release/rep_set/97_otus.fasta -O 159 -T 
#pick representative sequences for all split otu maps 
nohup pick_rep_set.py -i seqs.cat.combined.txt -f /data/seqs.cat.fna -o 
/data/rep_set/rep_set.fasta & 
nohup parallel_assign_taxonomy_uclust.py -i rep_set.fasta -o 
/data/uclust_assigned_taxonomy/ -O 8 & 
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cat seqs.cat_otus.txt seqs.cat_otus_failures.txt > seqs.cat_otus_merged.txt 
nohup make_otu_table.py -i otu_maps/seqs.cat_otus_merged.txt -o otu_table.biom -t 
uclust_assigned_taxonomy/rep_set _tax_assignments.txt & 
nohup parallel_align_seqs_pynast.py -i rep_set/rep_set_.fasta -o pynast_aligned_seqs/ -T -O 
8 & 
filter_alignment.py -o pynast_aligned_seqs/ -i pynast_aligned_seqs/rep_set _aligned.fasta 
nohup make_phylogeny.py -i pynast_aligned_seqs/rep_set _aligned_pfiltered.fasta -o 
rep_set.tre & 
# *** REMOVING NEGATIVE EXTRACTION AND NEGATIVE RUN CONTROL 
CONTAMINANTS *** 
split_otu_table.py -i otu_table.biom -m mapping_combined.txt -f BodySite -o split_by_site/ 
biom convert -i otu_table_Negative_extraction.biom -o otu_table_Negative_extraction.txt -b 
--header-key taxonomy 
filter_otus_from_otu_table.py -i otu_table.biom -o otu_table_c.biom -e 
contamination_otus.txt 
filter_otus_from_otu_table.py -i otu_table_c.biom -o otu_table_c_mc2.biom -n 2 
# *** ANALYSING MOCK COMMUNITY DATA *** 
biom convert -i otu_table_Mock_community.biom -o otu_table_Mock_community.txt -b --
header-key taxonomy 
# *** FILTERING OTU TABLE *** 
python filter_observations_by_sample.py -i combined/output/otu_table_c_mc2.biom -o 
combined/output/otu_table_c_f.biom -n 0.008 -f 
filter_samples_from_otu_table.py -i otu_table_c_f.biom -o otu_table_c_f_lf.biom -m 
mapping_combined.txt --output_mapping_fp mapping_combined_filtered.txt -n 1000 
filter_otus_from_otu_table.py -i otu_table_c_f_lf.biom -o otu_table_c_f_lf_mc2.biom -n 2 
biom summarize-table -i otu_table_c_f_lf_mc2.biom -o otu_table_c_f_lf_mc2_summary.txt 
single_rarefaction -i otu_table_f_c_mc2_lf_s_mc2.biom -o 
otu_table_f_c_mc2_lf_s_mc2_1000.biom -d 1000 
split_otu_table.py -i otu_table_c_f_lf_mc2.biom -m mapping_combined.txt -f BodySite -o 
split_by_site/ 
*** ALPHA DIVERSITY *** 
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alpha_rarefaction.py -i oral/otu_table_c_f_lf_mc2_Dental_plaque_Malawi.biom -m 
oral/mapping_Dental_plaque_Malawi.txt -o oral/alpha/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -n 1 --min_rare_depth 1000 -e 1000 
-p /home/ronan/miseq/combined/alpha_parameter.txt 
alpha_rarefaction.py -i vagina/otu_table_c_f_lf_mc2_Vaginal_mucus_Malawi.biom -m 
vagina/mapping_Vaginal_mucus_Malawi.txt -o vagina/alpha/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -n 1 --min_rare_depth 1000 -e 1000 
-p /home/ronan/miseq/combined/alpha_parameter.txt 
alpha_rarefaction.py -i placenta/otu_table_c_f_lf_mc2_Placenta_Malawi.biom -m 
placenta/mapping_Placenta_Malawi.txt -o placenta/alpha/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -n 1 --min_rare_depth 1000 -e 1000 
-p /home/ronan/miseq/combined/alpha_parameter.txt 
alpha_rarefaction.py -i membrane/otu_table_c_f_lf_mc2_Fetal_membrane_Malawi.biom -m 
membrane/mapping_Fetal_membrane_Malawi.txt -o membrane/alpha/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -n 1 --min_rare_depth 1000 -e 1000 
-p /home/ronan/miseq/combined/alpha_parameter.txt 
*** BETA DIVERSITY *** 
beta_diversity_through_plots.py -i oral/otu_table_c_f_lf_mc2_Dental_plaque_Malawi.biom 
-m oral/mapping_Dental_plaque_Malawi.txt -o oral/beta/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -p 
/home/ronan/miseq/combined/beta_parameter.txt -e 1000 
beta_diversity_through_plots.py -i 
vagina/otu_table_c_f_lf_mc2_Vaginal_mucus_Malawi.biom -m 
vagina/mapping_Vaginal_mucus_Malawi.txt -o vagina/beta/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -p 
/home/ronan/miseq/combined/beta_parameter.txt -e 1000 
beta_diversity_through_plots.py -i placenta/otu_table_c_f_lf_mc2_Placenta_Malawi.biom -
m placenta/mapping_Placenta_Malawi.txt -o placenta/beta/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -p 
/home/ronan/miseq/combined/beta_parameter.txt -e 1000 
beta_diversity_through_plots.py -i 
membrane/otu_table_c_f_lf_mc2_Fetal_membrane_Malawi.biom -m 
membrane/mapping_Fetal_membrane_Malawi.txt -o membrane/beta/ -t 
/home/ronan/miseq/combined/output/rep_set.tre -a -O 7 -p 
/home/ronan/miseq/combined/beta_parameter.txt -e 1000 
split_otu_table.py -i otu_table_f_c_mc2_lf_s_mc2.biom -m 
mapping/mapping_combined_filtered.txt -f BodySite -o split_by_site_filtered/ 
filter_otus_from_otu_table.py -i otu_table_f_c_mc2_lf_s_mc2_Dental_plaque_Malawi.biom 
-o otu_table_f_c_mc2_lf_s_mc2_Dental_plaque_Malawi_mc1.biom -n 1 
filter_otus_from_otu_table.py -i 
otu_table_f_c_mc2_lf_s_mc2_Fetal_membrane_Malawi.biom -o 
otu_table_f_c_mc2_lf_s_mc2_Fetal_membrane_Malawi_mc1.biom -n 1 
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filter_otus_from_otu_table.py -i otu_table_f_c_mc2_lf_s_mc2_Placenta_Malawi.biom -o 
otu_table_f_c_mc2_lf_s_mc2_Placenta_Malawi_mc1.biom -n 1 
filter_otus_from_otu_table.py -i 
otu_table_f_c_mc2_lf_s_mc2_Vaginal_mucus_Malawi.biom -o 
otu_table_f_c_mc2_lf_s_mc2_Vaginal_mucus_Malawi_mc1.biom -n 1 
